STOCK TITAN

CitroTech Inc. (NYSE American: CITR) posts Q2 2026 loss and flags going-concern risk

(Neutral)
(Neutral)
Form Type
10-Q/A

Rhea-AI Filing Summary

CitroTech Inc. filed an amendment to its June 30, 2026 quarterly report to add interactive data exhibits and refreshed officer certifications; the underlying second‑quarter 2026 financials remain unchanged. The company develops environmentally sustainable fire‑inhibiting chemicals and systems.

For the six months ended June 30, 2026, CitroTech generated $625,581 in revenue, down from $1,657,020 a year earlier, and recorded a net loss of $10.1 million versus $22.8 million in 2025. Q2 2026 revenue of $280,666 declined 59% year over year, while operating expenses were broadly flat. Significant non‑cash stock‑based compensation and prior‑year financing and derivative charges materially affect comparability.

At June 30, 2026, CitroTech held $2.5 million of cash, working capital of $3.3 million, total assets of $10.0 million, and an accumulated deficit of $123.3 million. Management states that existing cash will not fund commercial‑scale production and related working capital for the next 12 months, and explicitly discloses substantial doubt about the company’s ability to continue as a going concern. Management is evaluating additional equity or debt financing but notes there is no assurance of availability or terms.

Positive

  • None.

Negative

  • Substantial doubt about going concern: Management concludes current cash will not fund commercial‑scale operations for the next 12 months, raising substantial doubt about the company’s ability to continue as a going concern.
  • Sharp revenue contraction: Q2 2026 revenue fell to $280,666, a 59% decline from $687,638 in Q2 2025, reflecting weaker system and product sales during the fire season.
  • Large continuing losses: CitroTech reported a six‑month net loss of $10.1 million, following a $22.8 million loss in the prior‑year period, indicating ongoing heavy cash burn despite reduced financing‑related charges.

Filing Explained

The June 30 report shows 22,512,974 common shares outstanding, plus convertible preferred stock and warrants that can increase the common-share count.

The amendment is limited to filing exhibits and certifications, while the underlying June 30, 2026 report records 22,512,974 common shares outstanding.

It also reports 212,149 Series C shares outstanding, each convertible into 3.3333 common shares, and 2,754,641 outstanding warrants; these are potential additional common-share claims rather than issued common shares.

The report discloses later issuance of 37,500 common shares for COO restricted-stock-unit vesting and 3,000 shares to a consultant through August 7, 2026.

Revenue H1 2026 $625,581 Revenue for the six months ended June 30, 2026
Revenue Q2 2026 $280,666 Revenue for the three months ended June 30, 2026; 59% below Q2 2025
Net loss H1 2026 $10,113,118 Net loss for the six months ended June 30, 2026
Net loss H1 2025 $22,807,422 Prior-year net loss for the six months ended June 30, 2025
Cash balance $2,519,302 Cash as of June 30, 2026
Working capital $3.3 million Working capital at June 30, 2026 as discussed in liquidity note
Accumulated deficit $123,316,149 Accumulated deficit as of June 30, 2026
Net cash used in operations $3,842,728 Net cash used in operating activities for six months ended June 30, 2026
going concern financial
"These conditions raise substantial doubt about the Company's ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
additional paid-in capital financial
"Additional paid-in capital | | | 132,326,739"
Amount of money shareholders have paid to a company for shares that is above the stock’s nominal or par value; think of it as the extra premium paid when a group buys a ticket that has a low listed price. It matters to investors because it represents permanent capital on the balance sheet that can cushion losses, affect book value per share and indicate how much fresh cash equity holders have contributed beyond the minimum share value.
convertible notes financial
"The components of convertible notes as of June 30, 2026 and December 31, 2025, were as follows"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
accumulated deficit financial
"Accumulated deficit | | | ( 123,316,149 | )"
Accumulated deficit is the running total of a company’s past net losses minus any profits, showing how much the business has eaten into its own funds over time—think of it like a bank account that’s been overdrawn by repeated shortfalls. It matters to investors because a large accumulated deficit reduces the cushion that protects owners and creditors, can limit dividends or borrowing, and signals how much funding the company may need to reach profitability.
stock-based compensation financial
"During the three and six months ended June 30, 2026 and 2025, stock-based compensation was recognized as follows"
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
Revenue $625,581 Compared with $1,657,020 for the six months ended June 30, 2025
Net loss $10,113,118 Compared with net loss of $22,807,422 for the six months ended June 30, 2025
Q2 revenue $280,666 Down 59% from $687,638 in Q2 2025 as disclosed in the results table
Net cash used in operations $3,842,728 Net cash used in operating activities for six months ended June 30, 2026; prior-period value $1,925,535

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What was CitroTech Inc. (CITR) revenue for Q2 and the first half of 2026?

CitroTech reported Q2 2026 revenue of $280,666, down from $687,638 in Q2 2025, and first‑half 2026 revenue of $625,581, compared with $1,657,020 in the prior‑year period, reflecting lower system and product sales.

How much did CitroTech Inc. (CITR) lose in the first half of 2026?

CitroTech recorded a first‑half 2026 net loss of $10,113,118, compared with a net loss of $22,807,422 for the first half of 2025. Losses remain significant and are influenced by operating expenses and stock‑based compensation.

What is CitroTech Inc.’s (CITR) liquidity position as of June 30, 2026?

As of June 30, 2026, CitroTech had $2,519,302 in cash and working capital of approximately $3.3 million. Net cash used in operating activities was $3,842,728 for the first six months of 2026, indicating notable cash burn.

Did CitroTech Inc. (CITR) disclose going-concern risks in its latest quarter?

Yes. CitroTech disclosed that current cash is not sufficient to fund commercial‑scale production and related working capital for the next 12 months, stating that these conditions raise substantial doubt about its ability to continue as a going concern.

How has CitroTech Inc.’s (CITR) balance sheet changed since December 31, 2025?

Total assets declined from $14,183,519 to $10,036,040, while total liabilities fell from $2,920,605 to $1,023,178. Cash decreased from $6,268,591 to $2,519,302, and accumulated deficit widened to $123,316,149.

What major equity and debt actions did CitroTech Inc. (CITR) take in early 2026?

In the first half of 2026, CitroTech issued 3,990,659 common shares, converted $3,517,783 of debt into equity, exchanged 1,666,667 Series A preferred shares into Series C preferred, and eliminated all outstanding convertible notes and related‑party convertible debt.
true --12-31 2026 Q2 Amendment 1 0000894556 123316149 10113118 3842728 P5Y 1 0000894556 2026-01-01 2026-06-30 0000894556 2026-08-07 0000894556 2026-06-30 0000894556 2025-12-31 0000894556 us-gaap:SeriesAPreferredStockMember 2026-06-30 0000894556 us-gaap:SeriesAPreferredStockMember 2025-12-31 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2026-06-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2025-12-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-12-31 0000894556 2026-04-01 2026-06-30 0000894556 2025-04-01 2025-06-30 0000894556 2025-01-01 2025-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-12-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-12-31 0000894556 us-gaap:CommonStockMember 2025-12-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0000894556 us-gaap:RetainedEarningsMember 2025-12-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-03-31 0000894556 us-gaap:CommonStockMember 2026-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0000894556 us-gaap:RetainedEarningsMember 2026-03-31 0000894556 2026-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2024-12-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2024-12-31 0000894556 us-gaap:CommonStockMember 2024-12-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000894556 us-gaap:RetainedEarningsMember 2024-12-31 0000894556 2024-12-31 0000894556 CITR:SeriesAPreferredStocksMember 2025-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-03-31 0000894556 us-gaap:CommonStockMember 2025-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0000894556 us-gaap:RetainedEarningsMember 2025-03-31 0000894556 2025-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-01-01 2026-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-01-01 2026-03-31 0000894556 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0000894556 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0000894556 2026-01-01 2026-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2026-04-01 2026-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-04-01 2026-06-30 0000894556 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0000894556 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-01-01 2025-03-31 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-01-01 2025-03-31 0000894556 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000894556 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000894556 2025-01-01 2025-03-31 0000894556 CITR:SeriesAPreferredStocksMember 2025-04-01 2025-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-04-01 2025-06-30 0000894556 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0000894556 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2026-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2026-06-30 0000894556 us-gaap:CommonStockMember 2026-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0000894556 us-gaap:RetainedEarningsMember 2026-06-30 0000894556 CITR:SeriesAPreferredStocksMember 2025-06-30 0000894556 CITR:ConvertibleSeriesCPreferredStocksMember 2025-06-30 0000894556 us-gaap:CommonStockMember 2025-06-30 0000894556 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0000894556 us-gaap:RetainedEarningsMember 2025-06-30 0000894556 2025-06-30 0000894556 CITR:CostOfInventoryMember 2026-04-01 2026-06-30 0000894556 CITR:CostOfInventoryMember 2025-04-01 2025-06-30 0000894556 CITR:CostOfInventoryMember 2026-01-01 2026-06-30 0000894556 CITR:CostOfInventoryMember 2025-01-01 2025-06-30 0000894556 CITR:FreightAndShippingMember 2026-04-01 2026-06-30 0000894556 CITR:FreightAndShippingMember 2025-04-01 2025-06-30 0000894556 CITR:FreightAndShippingMember 2026-01-01 2026-06-30 0000894556 CITR:FreightAndShippingMember 2025-01-01 2025-06-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2026-04-01 2026-06-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2025-04-01 2025-06-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2026-01-01 2026-06-30 0000894556 CITR:ConsultingAndAdvisoryRelatedPartyMember 2025-01-01 2025-06-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2026-04-01 2026-06-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2025-04-01 2025-06-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2026-01-01 2026-06-30 0000894556 CITR:RoyaltyAndSalesCommissionRelatedPartyMember 2025-01-01 2025-06-30 0000894556 CITR:RentExpenseMember 2026-04-01 2026-06-30 0000894556 CITR:RentExpenseMember 2025-04-01 2025-06-30 0000894556 CITR:RentExpenseMember 2026-01-01 2026-06-30 0000894556 CITR:RentExpenseMember 2025-01-01 2025-06-30 0000894556 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-06-30 0000894556 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-06-30 0000894556 CITR:CommonStockWarrantsMember 2026-01-01 2026-06-30 0000894556 CITR:CommonStockWarrantsMember 2025-01-01 2025-06-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2026-01-01 2026-06-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-06-30 0000894556 CITR:ManagementCompensationMember 2026-04-01 2026-06-30 0000894556 CITR:ManagementCompensationMember 2025-04-01 2025-06-30 0000894556 CITR:ManagementCompensationMember 2026-01-01 2026-06-30 0000894556 CITR:ManagementCompensationMember 2025-01-01 2025-06-30 0000894556 CITR:ProfessionalFeesMember 2026-04-01 2026-06-30 0000894556 CITR:ProfessionalFeesMember 2025-04-01 2025-06-30 0000894556 CITR:ProfessionalFeesMember 2026-01-01 2026-06-30 0000894556 CITR:ProfessionalFeesMember 2025-01-01 2025-06-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2026-04-01 2026-06-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2025-04-01 2025-06-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2026-01-01 2026-06-30 0000894556 CITR:ProfessionalFeesRelatedPartyMember 2025-01-01 2025-06-30 0000894556 CITR:FinancingExpenseMember 2026-04-01 2026-06-30 0000894556 CITR:FinancingExpenseMember 2025-04-01 2025-06-30 0000894556 CITR:FinancingExpenseMember 2026-01-01 2026-06-30 0000894556 CITR:FinancingExpenseMember 2025-01-01 2025-06-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2026-04-01 2026-06-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2025-04-01 2025-06-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2026-01-01 2026-06-30 0000894556 CITR:FinancingExpenseRelatedPartyMember 2025-01-01 2025-06-30 0000894556 CITR:InsuranceMember 2026-06-30 0000894556 CITR:InsuranceMember 2025-12-31 0000894556 CITR:LegalRetainerMember 2026-06-30 0000894556 CITR:LegalRetainerMember 2025-12-31 0000894556 CITR:ResearchAndDevelopmentExpensesMember 2026-06-30 0000894556 CITR:ResearchAndDevelopmentExpensesMember 2025-12-31 0000894556 CITR:AdvertisingAndMarketingMember 2026-06-30 0000894556 CITR:AdvertisingAndMarketingMember 2025-12-31 0000894556 CITR:OtherPrepaidOperatingExpensesMember 2026-06-30 0000894556 CITR:OtherPrepaidOperatingExpensesMember 2025-12-31 0000894556 CITR:DepositOnPurchaseOfInventoriesMember 2026-06-30 0000894556 CITR:DepositOnPurchaseOfInventoriesMember 2025-12-31 0000894556 us-gaap:EquipmentMember 2026-06-30 0000894556 us-gaap:EquipmentMember 2025-12-31 0000894556 us-gaap:VehiclesMember 2026-06-30 0000894556 us-gaap:VehiclesMember 2025-12-31 0000894556 us-gaap:EquipmentMember 2026-01-01 2026-06-30 0000894556 CITR:VehiclesAndEquipmentMember 2025-01-01 2025-06-30 0000894556 CITR:VehiclesAndEquipmentMember CITR:FinancedMember 2025-01-01 2025-06-30 0000894556 us-gaap:VehiclesMember 2025-01-01 2025-06-30 0000894556 CITR:VehiclesAndEquipmentMember 2026-01-01 2026-06-30 0000894556 CITR:OtherCurrentLiabilitySettledMember 2026-01-01 2026-06-30 0000894556 CITR:September2025VehicleMember 2025-09-01 2025-09-30 0000894556 CITR:September2025Vehicle1Member 2025-09-01 2025-09-30 0000894556 CITR:September2025VehicleMember 2026-01-01 2026-06-30 0000894556 CITR:FinancingLoanMember 2026-04-01 2026-06-30 0000894556 CITR:FinancingLoanMember 2025-04-01 2025-06-30 0000894556 CITR:FinancingLoanMember 2026-01-01 2026-06-30 0000894556 CITR:FinancingLoanMember 2025-01-01 2025-06-30 0000894556 us-gaap:IntellectualPropertyMember 2025-12-01 2025-12-31 0000894556 us-gaap:PatentsMember 2026-06-30 0000894556 us-gaap:PatentsMember 2025-12-31 0000894556 us-gaap:TechnologyBasedIntangibleAssetsMember 2026-06-30 0000894556 us-gaap:TechnologyBasedIntangibleAssetsMember 2025-12-31 0000894556 us-gaap:NoncompeteAgreementsMember 2026-06-30 0000894556 us-gaap:NoncompeteAgreementsMember 2025-12-31 0000894556 2025-01-31 0000894556 CITR:February152025Member CITR:ConvertibleNotesMember 2026-06-30 0000894556 CITR:February152025Member CITR:ConvertibleNotesMember 2026-01-01 2026-06-30 0000894556 CITR:February152025Member CITR:ConvertibleNotesMember 2025-12-31 0000894556 CITR:ConvertibleNotesMember 2026-06-30 0000894556 CITR:ConvertibleNotesMember 2025-12-31 0000894556 CITR:ConvertibleNotesMember 2026-04-01 2026-06-30 0000894556 CITR:ConvertibleNotesMember 2025-04-01 2025-06-30 0000894556 CITR:ConvertibleNotesMember 2026-01-01 2026-06-30 0000894556 CITR:ConvertibleNotesMember 2025-01-01 2025-06-30 0000894556 CITR:ConvertibleNotesFeb2025Member CITR:NoteHolders7Member 2026-02-01 2026-02-28 0000894556 CITR:ConvertibleNotesFeb2025Member CITR:NoteHolders7Member 2026-02-28 0000894556 CITR:AcctsPayableMember 2026-06-30 0000894556 CITR:AcctsPayableMember 2025-12-31 0000894556 CITR:AccruedInterestPayableMember 2026-06-30 0000894556 CITR:AccruedInterestPayableMember 2025-12-31 0000894556 CITR:CreditCardPayableMember 2026-06-30 0000894556 CITR:CreditCardPayableMember 2025-12-31 0000894556 CITR:SalesTaxPayableMember 2026-06-30 0000894556 CITR:SalesTaxPayableMember 2025-12-31 0000894556 CITR:OtherLiabilityMember 2026-06-30 0000894556 CITR:OtherLiabilityMember 2025-12-31 0000894556 CITR:PayrollLiabilityMember 2026-06-30 0000894556 CITR:PayrollLiabilityMember 2025-12-31 0000894556 CITR:RelatedPartyAMember CITR:OperatingExpensesMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyAMember CITR:OperatingExpensesMember 2025-01-01 2025-12-31 0000894556 CITR:RelatedPartyFMember CITR:ConvertibleNoteAccruedInterestRelatedPartyMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyFMember CITR:ConvertibleNoteAccruedInterestRelatedPartyMember 2025-01-01 2025-12-31 0000894556 CITR:RelatedPartyGMember CITR:ConsultingFeesMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyGMember CITR:ConsultingFeesMember 2025-01-01 2025-12-31 0000894556 2025-01-01 2025-12-31 0000894556 CITR:RelatedPartyAMember CITR:PaymentOfOperatingExpensesOnBehalfOfTheCompanyMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyAMember CITR:PaymentOfOperatingExpensesOnBehalfOfTheCompanyMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyAMember CITR:RepaymentOfLoanMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyAMember CITR:RepaymentOfLoanMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyCMember CITR:CashPaidForConsultingFeesMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyCMember CITR:CashPaidForConsultingFeesMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForRoyaltyAndSalesCommissionsMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForRoyaltyAndSalesCommissionsMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForConsultingFeesMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForConsultingFeesMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyFMember CITR:SeriesCPreferredStockForServicesMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyFMember CITR:SeriesCPreferredStockForServicesMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2026-04-01 2026-06-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2025-04-01 2025-06-30 0000894556 CITR:RelatedPartyAMember CITR:SeriesCPreferredStockForConsultingFeeMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyAMember CITR:SeriesCPreferredStockForConsultingFeeMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyAMember CITR:PaymentOfOperatingExpensesOnBehalfOfTheCompanyMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyAMember CITR:PaymentOfOperatingExpensesOnBehalfOfTheCompanyMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyAMember CITR:RepaymentOfLoanMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyAMember CITR:RepaymentOfLoanMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyCMember CITR:CashPaidForConsultingFeesMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyCMember CITR:CashPaidForConsultingFeesMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyCMember CITR:ConsultingAndAdvisoryFeesMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyCMember CITR:ConsultingAndAdvisoryFeesMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForRoyaltyAndSalesCommissionsMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForRoyaltyAndSalesCommissionsMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForConsultingFeesMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyDMember CITR:CashPaidForConsultingFeesMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyEMember CITR:ManagementCompensationMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyEMember CITR:ManagementCompensationMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyEMember CITR:AdvisoryFeeMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyEMember CITR:AdvisoryFeeMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyFMember CITR:SeriesCPreferredStockForServicesMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyFMember CITR:SeriesCPreferredStockForServicesMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyGMember CITR:EdgarFilingExpenseMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyGMember CITR:EdgarFilingExpenseMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2026-01-01 2026-06-30 0000894556 CITR:RelatedPartyGMember CITR:ProfessionalServiceAccountingMember 2025-01-01 2025-06-30 0000894556 CITR:RelatedPartyBMember 2026-02-01 2026-02-28 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member CITR:RelatedPartyFMember 2025-02-28 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member CITR:RelatedPartyFMember CITR:OIDAndFinancingFeeMember 2025-02-28 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-04-01 2026-04-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-04-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-06-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2025-12-31 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member 2026-06-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member 2026-01-01 2026-06-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember CITR:February2025Member 2025-12-31 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-04-01 2026-06-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2025-04-01 2025-06-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2026-01-01 2026-06-30 0000894556 CITR:ConvertibleNotesRelatedPartiesMember 2025-01-01 2025-06-30 0000894556 CITR:ExchangeAgreementsMember us-gaap:SeriesAPreferredStockMember 2026-05-27 2026-05-28 0000894556 CITR:ExchangeAgreementsMember CITR:SeriesCConvertiblePreferredStockMember 2026-05-28 0000894556 CITR:ExchangeAgreementsMember us-gaap:SeriesCPreferredStockMember 2026-05-28 0000894556 CITR:ExchangeAgreementsMember us-gaap:SeriesCPreferredStockMember 2026-05-27 2026-05-28 0000894556 us-gaap:SeriesCPreferredStockMember 2026-06-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2026-01-01 2026-06-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember 2025-06-30 0000894556 CITR:SeriesCConvertiblePreferredStockMember CITR:SubscriptionsMember 2026-01-01 2026-06-30 0000894556 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-06-30 0000894556 us-gaap:CommonStockMember 2026-01-01 2026-06-30 0000894556 CITR:DebtConvertedIntoCommonStockMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0000894556 CITR:CashlessExerciseOfWarrantsMember us-gaap:CommonStockMember 2026-01-01 2026-06-30 0000894556 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0000894556 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0000894556 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-06-30 0000894556 CITR:DebtConvertedIntoCommonStockMember us-gaap:CommonStockMember 2025-01-01 2025-06-30 0000894556 CITR:RestrictedStockAwardMember srt:ChiefOperatingOfficerMember 2025-06-26 2025-06-27 0000894556 CITR:RestrictedStockAwardMember srt:ChiefExecutiveOfficerMember 2025-09-21 2025-09-22 0000894556 CITR:RestrictedStockAwardMember 2026-04-01 2026-06-30 0000894556 CITR:RestrictedStockAwardMember 2026-01-01 2026-06-30 0000894556 CITR:RestrictedStockAwardMember 2026-06-30 0000894556 CITR:FormerCEOAndCurrentChairmanMember CITR:ManagementCompensationPSUMember 2026-01-01 2026-06-30 0000894556 srt:DirectorMember CITR:ManagementCompensationPSUMember 2026-01-01 2026-06-30 0000894556 srt:ChiefOperatingOfficerMember CITR:ManagementCompensationPSUMember 2026-01-01 2026-06-30 0000894556 srt:ChiefExecutiveOfficerMember CITR:ManagementCompensationPSUMember 2026-01-01 2026-06-30 0000894556 CITR:ManagementCompensationPSUMember 2026-01-01 2026-06-30 0000894556 CITR:ManagementCompensationPSUMember 2026-04-01 2026-06-30 0000894556 CITR:ManagementCompensationPSUMember 2026-06-30 0000894556 srt:ChiefExecutiveOfficerMember us-gaap:SeriesCPreferredStockMember 2026-06-30 0000894556 srt:ChiefExecutiveOfficerMember us-gaap:CommonStockMember 2026-06-30 0000894556 srt:ChiefOperatingOfficerMember us-gaap:CommonStockMember 2026-06-30 0000894556 CITR:RelatedPartyFMember 2026-04-30 0000894556 CITR:RelatedPartyFMember 2026-04-01 2026-04-30 0000894556 CITR:WarrantsMember 2026-01-01 2026-06-30 0000894556 CITR:CompensationAwardsMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:FirstCapitalizationMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:SecondCapitalizationMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:ThirdCapitalizationMember 2025-01-01 2025-12-31 0000894556 CITR:CompensationAwardsMember CITR:FourthCapitalizationMember 2025-01-01 2025-12-31 0000894556 us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-06-30 0000894556 us-gaap:MeasurementInputPriceVolatilityMember 2026-01-01 2026-06-30 0000894556 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-01-01 2026-06-30 0000894556 us-gaap:MeasurementInputExpectedDividendRateMember 2026-01-01 2026-06-30 0000894556 CITR:ProductsSaleMember 2026-04-01 2026-06-30 0000894556 CITR:ProductsSaleMember 2025-04-01 2025-06-30 0000894556 CITR:ProductsSaleMember 2026-01-01 2026-06-30 0000894556 CITR:ProductsSaleMember 2025-01-01 2025-06-30 0000894556 CITR:ProductInstallationServiceMember 2026-04-01 2026-06-30 0000894556 CITR:ProductInstallationServiceMember 2025-04-01 2025-06-30 0000894556 CITR:ProductInstallationServiceMember 2026-01-01 2026-06-30 0000894556 CITR:ProductInstallationServiceMember 2025-01-01 2025-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-04-01 2026-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-04-01 2025-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2026-04-01 2026-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2025-04-01 2025-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2026-01-01 2026-06-30 0000894556 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember CITR:FiveCustomersMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CITR:CustomersMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember CITR:CustomersMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierAMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierBMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierCMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierDMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierEMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:SupplierFMember 2025-01-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2026-04-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2025-04-01 2025-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2026-01-01 2026-06-30 0000894556 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2025-01-01 2025-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2026-01-01 2026-06-30 0000894556 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember CITR:AllSuppliersMember 2025-01-01 2025-06-30 0000894556 CITR:ReportingSegmentMember 2026-04-01 2026-06-30 0000894556 CITR:ReportingSegmentMember 2025-04-01 2025-06-30 0000894556 CITR:ReportingSegmentMember 2026-01-01 2026-06-30 0000894556 CITR:ReportingSegmentMember 2025-01-01 2025-06-30 0000894556 CITR:ReportingSegmentMember 2026-06-30 0000894556 CITR:ReportingSegmentMember 2025-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CITR:Integer CITR:Customer

Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q/A

(Amendment 1)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the quarterly period ended: June 30, 2026

 

or

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from ___________ to ___________

 

Commission File Number: 001-42983

 

CitroTech Inc.
(Exact name of registrant as specified in its charter)

 

Wyoming   87-2765150
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     

6400 S. Fiddlers Green Cir., Suite 300

Greenwood Village, Colorado

  80111
(Address of principal executive offices)   (Zip Code)

 

(800401-4535

(Registrant’s telephone number, including area code)

  

Securities registered pursuant to Section 12(b) of the Act: 
 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   CITR   NYSE American LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) ☐YES      NO

 

As of August 7, 2026, 22,553,474 shares of the Company’s common stock were issued and outstanding.

 

 

   

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-Q/A (this “Amendment”) to the Quarterly Report on Form 10-Q of CitroTech Inc. for the quarterly period ended June 30, 2026, originally filed with the Securities and Exchange Commission (the “SEC”) on August 10, 2026 (the “Original Filing”), is being filed solely to include the Interactive Data Files included as Exhibit 101 and Exhibit 104 in accordance with Rule 405 of Regulation S-T.

 

In connection with this Amendment, and as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, the Company is including new certifications from its principal executive officer and principal financial officer as Exhibits 31.1, 31.2, 32.1 and 32.2.

 

This Amendment does not modify, amend or update the financial statements, disclosures or other information contained in the Original Filing. Accordingly, this Amendment does not reflect events occurring after the filing date of the Original Filing and does not modify or update the disclosures in the Original Filing for any subsequent events.

 

Except as described above, no changes have been made to the Original Filing.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

 

TABLE OF CONTENTS

 

    Page  
       
PART I - FINANCIAL INFORMATION   3  
         
Item 1. Financial Statements   3  
         
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   30  
         
Item 3. Quantitative and Qualitative Disclosures About Market Risk   41  
         
Item 4. Controls and Procedures   42  
       
PART II - OTHER INFORMATION   43  
       
Item 1. Legal Proceedings   43  
         
Item 1A. Risk Factors   43  
         
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   43  
         
Item 3. Defaults Upon Senior Securities   43  
         
Item 4. Mine Safety Disclosures   43  
         
Item 5. Other Information   43  
         
Item 6. Exhibits   44  
         
SIGNATURES   45  

 

 

 

 

 3 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Index to Unaudited Interim Consolidated Financial Statements

June 30, 2026

 

  

 

Contents   Page  
       
Consolidated Balance Sheets at June 30, 2026 and December 31, 2025   4  
       
Consolidated Statements of Operations and Comprehensive Loss for the three and six months ended June 30, 2026 and 2025   5  
       
Consolidated Statements of Changes in Stockholders’ Equity for the three and six months ended June 30, 2026 and 2025   6  
       
Consolidated Statements of Cash Flows for the six months ended June 30, 2026 and 2025   8  
       
Notes to Unaudited Interim Consolidated Financial Statements   9  


 

 

 

 

 

 

 

 

 

 

 

 4 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Balance Sheets

(Unaudited)

 

           
   June 30,   December 31, 
   2026   2025 
Assets          
Current Assets          
Cash  $2,519,302   $6,268,591 
Accounts receivable, net   165,436    209,047 
Inventory   579,125    620,768 
Prepaid expenses and other current assets   418,804    317,020 
Total Current Assets   3,682,667    7,415,426 
           
Non-Current Assets          
Intangible assets, net   5,136,030    5,326,960 
Operating lease right-of-use asset   675,802    753,363 
Equipment, net   484,050    630,279 
Security deposit   57,491    57,491 
Total Non-Current Assets   6,353,373    6,768,093 
           
Total Assets  $10,036,040   $14,183,519 
           
Liabilities and Stockholders' Equity          
Current liabilities          
Accounts payable and accrued liabilities  $221,820   $316,321 
Deferred revenue   21,394    3,000 
Convertible notes, net of discount       219,321 
Convertible notes, net of discount - related parties       1,285,400 
Due to related parties   5,200    167,971 
Financing loan - current portion   14,871    30,000 
Operating lease liability - current portion   156,803    147,613 
Total Current Liabilities   420,088    2,169,626 
           
Non-Current Liabilities          
Financing loan   66,242    133,381 
Operating lease liability   536,848    617,598 
Total Non-Current Liabilities   603,090    750,979 
           
Total Liabilities   1,023,178    2,920,605 
           
Stockholders' Equity          
Preferred Stock, par value $0.0001, authorized 30,000,000 shares:          
Series A Preferred Stock, par value $0.0001, designated 10,000,000 shares, 0 and 1,666,667 shares issued and outstanding, respectively       167 
Series C Convertible Preferred Stock, par value $0.0001, designated 10,000,000 shares, 212,149 and 807,668 shares issued and outstanding, respectively   21    81 
Common Stock, par value $0.0001, authorized 1,000,000,000 shares, 22,512,974 and 18,522,315 issued and outstanding, respectively   2,251    1,852 
Additional paid-in capital   132,326,739    124,463,845 
Accumulated deficit   (123,316,149)   (113,203,031)
Total Stockholders' Equity   9,012,862    11,262,914 
Total Liabilities and Stockholders' Equity  $10,036,040   $14,183,519 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 5 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

                     
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
                 
Revenue  $280,666   $687,638   $625,581   $1,657,020 
                     
Operating expenses                    
Cost of revenue, exclusive of amortization and depreciation shown separately below   271,628    371,392    497,205    928,362 
Cost of revenue - related parties               60,290 
Amortization and depreciation   123,850    77,107    249,534    151,646 
General and administrative   218,290    270,227    628,246    473,398 
Advertising and marketing   210,792    152,608    348,392    257,104 
Payroll and management compensation   2,061,328    2,334,698    5,168,695    3,008,121 
Professional fees   648,710    445,668    1,328,552    1,072,986 
Professional fees - related parties   43,150    12,300    67,660    2,131,900 
Research and development expense   197,067    41,276    278,592    49,307 
Total operating expenses   3,774,815    3,705,276    8,566,876    8,133,114 
                     
Loss from operations   (3,494,149)   (3,017,638)   (7,941,295)   (6,476,094)
                     
Other income (expense)                    
Interest expense   (3,569)   (552,085)   (168,402)   (962,876)
Interest expense - related party   (27,562)   (212,787)   (804,847)   (274,843)
Interest income   16,784    3,958    42,850    3,958 
Financing expense               (6,167,334)
Financing expense - related party   (361,801)   (2,511,855)   (361,801)   (2,511,855)
Loss on fair value of derivative liability       (2,973,000)       (3,777,767)
Loss on sales of assets   (32,257)       (32,257)    
Loss on settlement of debt       (2,640,611)   (847,366)   (2,640,611)
Total other expense   (408,405)   (8,886,380)   (2,171,823)   (16,331,328)
                     
Loss before taxes   (3,902,554)   (11,904,018)   (10,113,118)   (22,807,422)
                     
Provision for income taxes                
Net loss  $(3,902,554)  $(11,904,018)  $(10,113,118)  $(22,807,422)
                     
Comprehensive loss  $(3,902,554)  $(11,904,018)  $(10,113,118)  $(22,807,422)
                     
Net loss per common share - basic and diluted  $(0.18)  $(1.14)  $(0.50)  $(2.47)
Basic and diluted weighted average number of common shares outstanding   21,754,514    10,455,720    20,301,861    9,225,515 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 6 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the three and six months ended June 30, 2026

 

                                           
   Series A   Series C Convertible           Additional       Total 
   Preferred stock   Preferred stock   Common Stock   Paid-In   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
                                     
Balance - December 31, 2025  1,666,667   $167   807,668   $81   18,522,315   $1,852   $124,463,845   $(113,203,031)  $11,262,914 
Common stock issued for conversion of debt                171,878    17    1,259,849        1,259,866 
Common stock issued for services                22,000    2    160,378        160,380 
Common stock issued for cashless exercise of warrants                180,708    18    (18)        
Common stock issued for stock payable                220,000    22    (22)        
Management stock compensation                        2,116,178        2,116,178 
Contributed capital                        96,258        96,258 
Net loss                            (6,210,564)   (6,210,564)
Balance - March 31, 2026  1,666,667   $167   807,668   $81   19,116,901   $1,911   $128,096,468   $(119,413,595)  $8,685,032 
Series A Preferred Stock exchanged for Series C Preferred Stock and Series C Preferred Stock payable  (1,666,667)   (167)  103,558    10           157         
Common stock issued for conversion of Series C Preferred Stock         (699,077)   (70)  2,330,273    233    (163)        
Common stock issued for services                33,333    4    282,993        282,997 
Common stock issued for conversion of debt                940,799    94    2,257,823        2,257,917 
Common stock issued for exercise of warrants                8,334    1    25,001        25,002 
Management stock compensation                83,334    8    1,302,659        1,302,667 
Warrants issued for services                        361,801        361,801 
Net loss                            (3,902,554)   (3,902,554)
Balance - June 30, 2026     $   212,149   $21   22,512,974   $2,251   $132,326,739   $(123,316,149)  $9,012,862 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 7 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

 

For the three and six months ended June 30, 2025

 

   Series A   Convertible Series C           Additional       Total 
   Preferred stock   Preferred stock   Common Stock   Paid-In   Accumulated   Stockholders' 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Deficit   Equity 
                                     
Balance - December 31, 2024  1,666,667   $167   3,001,969   $300   6,140,264   $614   $79,680,114   $(76,365,388)  $3,315,807 
                                           
Series C Preferred Stock issued for cash         27,500    3           259,997        260,000 
Series C Preferred Stock issued for services         167,500    17           2,349,003        2,349,020 
Series C Preferred Stock issued for compensation         30,000    3           420,717        420,720 
Common stock issued for conversion of Series C Preferred Stock         (776,831)   (78)  2,589,450    259    (181)        
Common stock warrants issued                        8,649,503        8,649,503 
Net loss                            (10,903,404)   (10,903,404)
Balance - March 31, 2025  1,666,667    167   2,450,138    245   8,729,714    873    91,359,153    (87,268,792)   4,091,646 
                                           
Series C Preferred Stock issued for services         69,007    7           2,511,848        2,511,855 
Series C Preferred Stock for compensation         50,000    5           1,099,995        1,100,000 
Common stock issued for conversion of Series C Preferred Stock         (532,638)   (53)  1,775,466    178    (125)        
Common stock issued for services                1,667        19,000        19,000 
Common stock issued for conversion of debts                507,661    51    5,604,391        5,604,442 
Management stock compensation                        767,669        767,669 
Net loss                            (11,904,018)   (11,904,018)
Balance - June 30, 2025  1,666,667   $167   2,036,507   $204   11,014,508   $1,102   $101,361,931   $(99,172,810)  $2,190,594 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 

 8 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Consolidated Statements of Cash Flows

(Unaudited)

 

           
   Six months ended 
   June 30, 
   2026   2025 
Cash Flows from Operating Activities:          
Net loss  $(10,113,118)  $(22,807,422)
Adjustments to reconcile net loss to net cash used in operating activities:          
Stock-based compensation   443,377    8,720,143 
Stock-based compensation - related party   3,780,646    4,615,455 
Bad debt expense recovery   (20,000)    
Non-cash lease expenses   77,561    86,052 
Amortization and depreciation   249,534    151,646 
Amortization of debt discount   892,279    1,000,390 
Loss on settlement of debt   847,366    2,640,611 
Loss on fair value of derivative liability       3,777,767 
Loss on disposal of equipment   32,257     
Changes in operating assets and liabilities:          
Accounts receivable   63,611    (336,540)
Inventory   41,643    (180,563)
Prepaid expenses and other current assets   (101,784)   (132,241)
Security deposit       (36,991)
Accounts payable and accrued liabilities   (56,080)   443,354 
Due to related parties   4,900    25,300 
Accrued interest - related parties   68,246    95,447 
Deferred revenue   18,394    94,860 
Operating lease liabilities   (71,560)   (82,803)
Net Cash used in Operating Activities   (3,842,728)   (1,925,535)
           
Cash Flows from Investing Activities:          
Purchase of equipment   (10,727)   (167,744)
Sale of equipment   12,500     
Net Cash provided by (used in) Investing Activities   1,773    (167,744)
           
Cash Flows from Financing Activities:          
Proceeds from exercise of warrants   25,002     
Proceeds from convertible notes and warrants       1,909,000 
Proceeds from convertible note and warrants - related party       1,776,082 
Payments of deferred offering costs       (59,223)
Contributed capital   96,258     
Repayment of loan - related party       (25,000)
Proceeds from issuance of Series C Preferred Stock and warrants       260,000 
Repayment of financing loan   (29,594)   (215,625)
Net Cash provided by Financing Activities   91,666    3,645,234 
           
Change in cash   (3,749,289)   1,551,955 
Cash, beginning of period   6,268,591    775,133 
Cash, end of period  $2,519,302   $2,327,088 
           
Supplemental Disclosure Information:          
Cash paid for interest  $7,997   $5,870 
Cash paid for taxes  $   $ 
           
Non-Cash Financing Disclosure:          
Series A Preferred Stock exchanged for Series C Preferred Stock and Series C Preferred Stock payable  $157   $ 
Common stock issued upon conversion of Series C Preferred stock  $   $2,618 
Common stock issued for conversion and settlement of debt  $1,259,866   $5,604,442 
Debt modification  $200,000   $ 
Warrants issued in conjunction with convertible debts  $2,222,000   $882,000 
Right-of-use assets obtained in exchange for new operating lease liabilities  $   $865,218 
Recognition of derivative liability as debt discount  $   $1,027,000 
Transfer from inventory to property and equipment  $   $74,827 
Acquisition of property and equipment as financing loan  $   $118,776 

 

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

 

 

 

 9 

 

 

CitroTech Inc.

(formerly General Enterprise Ventures, Inc.)

Notes to Unaudited Interim Consolidated Financial Statements

June 30, 2026

 

Note 1 – Organization, Business and Going Concern

 

CitroTech Inc. was originally incorporated under the laws of the State of Nevada on March 14, 1990 and on June 3, 2021 was redomiciled to the State of Wyoming. Effective on January 22, 2026, the Company changed its name from General Enterprise Ventures, Inc. to CitroTech Inc. When used in these notes, the terms “CITR,” “Company,” “we,” “us” and “our” mean CitroTech Inc. and all entities included in our unaudited interim consolidated financial statements.

 

Business

 

We develop and manufacture environmentally sustainable, non-toxic, long-term fire-inhibiting products for use in industrial and wildfire defense applications. The Company’s proprietary formulation, CitroTech®, is derived from food-grade, renewable materials and is designed to provide an alternative to legacy conventional chemical fire retardants. CitroTech is used in the manufacturing of fire-resilient lumber and building materials, enabling integration of flame-inhibiting properties during production or applied in the field to new homes. In addition, it is utilized by fire departments, municipalities, and other public and private sector entities in connection with ground-based wildfire defense and stationary application systems intended to help render vegetation non-flammable, reduce ignition risk and enhance structural protection.

 

The Company continues to evaluate and develop additional formulations and product treatments to expand the range of potential commercial applications for its technology.

  

Liquidity and Going Concern

 

The accompanying unaudited interim consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business.

 

At June 30, 2026, the Company had cash of approximately $2.5 million, working capital of $3.3 million, and an accumulated deficit of $123.3 million. For the six months ended June 30, 2026, the Company incurred a net loss of $10.1 million and used approximately $3.8 million of cash in operating activities. The Company's ability to continue as a going concern depends on its ability to scale commercial sales. Management believes that current cash is not sufficient to fund commercial-scale production and the related working capital requirements for the next twelve months. These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year following the issuance date of these unaudited interim consolidated financial statements.

 

To alleviate these conditions, management is currently evaluating various funding alternatives and may seek to raise additional funds through the issuance of equity or debt securities. As we seek additional sources of financing, there can be no assurance that such financing would be available to us on favorable terms or at all. Our ability to obtain additional financing in the capital markets is subject to several factors, including market and economic conditions, our performance and investor sentiment with respect to us and our industry.

 

 

 

 

 10 

 

 

Note 2 – Summary of Significant Accounting Policies

 

Basis of Presentation

 

Our unaudited interim consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited interim consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated Financial Statements included in the Annual Report on Form 10-K of CitroTech Inc. for the year ended December 31, 2025.

 

In the opinion of management, the accompanying unaudited interim consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of June 30, 2026 and its results of operations for the three and six months ended June 30, 2026 and 2025, and cash flows for the six months ended June 30, 2026 and 2025. The balance sheet at December 31, 2025, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.

 

The accompanying unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K, for the year ended December 31, 2025, as filed with the SEC on March 30, 2026.

  

Principles of Consolidation

 

The consolidated financial statements include the accounts of CitroTech Inc., and its wholly owned subsidiaries. Intercompany transactions and balances have been eliminated.

 

Reclassification

 

Certain amounts have been reclassified to improve the clarity and comparability of the financial statements. These reclassifications had no impact on previously reported total assets, liabilities, equity, net income (loss), or cash flows for any periods presented.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.

 

Cash and Cash Equivalents

 

For purposes of balance sheet presentation and reporting of cash flows, the Company considers all unrestricted demand deposits, money market funds and highly liquid debt instruments with an original maturity of less than 90 days to be cash and cash equivalents. The Company did not have any cash equivalents at June 30, 2026 and December 31, 2025. The Company had cash of $2.5 million and $6.3 million at June 30, 2026 and December 31, 2025, respectively.

 

Periodically, the Company may carry cash balances at financial institutions more than the federally insured limit of $250,000 per institution. The amount in excess of the FDIC insurance as of June 30, 2026, was approximately $1.9 million. The Company has not experienced losses on account balances and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.

 

 

 

 11 

 

 

Accounts Receivable

 

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any expected loss on the trade accounts receivable balances and charged to the provision for credit loss. The Company maintains allowances for credit loss for estimated losses resulting from the inability of its customers to make the required payments for services. Accounts with known financial issues are first reviewed and specific estimates are recorded. The remaining accounts receivable balances are then grouped in categories by the number of days the balance is past due, and the estimated loss is calculated as a percentage of the total category based upon past history. Account balances are charged against the allowance when it is probable that the receivable will not be recovered.

  

During the three months ended June 30, 2026, the Company recovered $20,000 of previously reserved accounts receivable. Accordingly, the Company reversed the related allowance for credit losses, which was recorded as a reduction of general and administrative expenses. As of June 30, 2026, the Company determined that the remaining reserved accounts receivable balance was uncollectible and wrote it off against the existing allowance for credit losses. The allowance for credit losses was $0 and $340,950 as of June 30, 2026 and December 31, 2025, respectively.

 

Fair Value of Financial Instruments 

 

The Company uses a three-tier fair value hierarchy to classify and disclose all assets and liabilities measured at fair value on a recurring basis, as well as assets and liabilities measured at fair value on a non-recurring basis, in periods subsequent to their initial measurement. The hierarchy requires the Company to use observable inputs when available, and to minimize the use of unobservable inputs, when determining fair value. The three tiers are defined as follows:

 

  Level 1—Observable inputs that reflect quoted market prices (unadjusted) for identical assets or liabilities in active markets;
   
  Level 2—Observable inputs other than quoted prices in active markets that are observable either directly or indirectly in the marketplace for identical or similar assets and liabilities; and
   
  Level 3—Unobservable inputs that are supported by little or no market data, which require the Company to develop its own assumptions.

 

Financial instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires the Company to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts recorded, may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.

  

The Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable and accrued liabilities, deferred revenue and loans payable, are carried at historical cost. As of June 30, 2026 and December 31, 2025, the carrying amounts of these instruments approximated their fair values because of the short-term nature of these instruments.

 

Convertible Notes

 

The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

 

 

 

 12 

 

 

Related Parties

 

The Company follows ASC 850, “Related Party Disclosures,” for the identification of related parties and disclosure of related party transactions.

 

Revenue

 

The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

 

Revenue related to contracts with customers is evaluated utilizing the following steps:

 

  i. Identify the contract, or contracts, with a customer;
  ii. Identify the performance obligations in the contract;
  iii. Determine the transaction price;
  iv. Allocate the transaction price to the performance obligations in the contract;
  v. Recognize revenue when the Company satisfies a performance obligation.

 

For the six months ended June 30, 2026, our revenues currently consist of a sale of product used for lumber products for fire prevention and on installation of self-contained sprinkler systems. Revenue is recognized at a point in time when the risks and rewards of ownership of the product transfer from the Company to the customer.

 

Deferred revenue

 

Deferred revenue consists of advanced payments for our service that have not been rendered. Revenue is recognized when service is rendered. As of June 30, 2026 and December 31, 2025, total deferred revenue was $21,394 and $3,000, respectively. Deferred revenue is expected to be recognized as revenue within the third and fourth quarters of 2026.

 

Cost of Revenue

 

For the three and six months ended June 30, 2026 and 2025, cost of revenue consisted of: 

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Cost of inventory  $207,418   $304,791   $372,848   $821,234 
Freight and shipping   5,629    5,899    8,090    6,059 
Consulting and advisory-related party               4,000 
Royalty and sales commission-related party               56,290 
Rent expense   58,581    60,702    116,267    101,069 
Total cost of revenue  $271,628   $371,392   $497,205   $988,652 

 

 

 

 13 

 

 

Basic and Diluted Net Loss Per Common Share

 

Net loss per share of common stock requires presentation of basic and diluted earnings per common share on the face of the Statements of Operations for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic earnings per share computation to diluted earnings per share. In the accompanying financial statements, basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements and warrants unless the result would be antidilutive.

 

The dilutive effect of share-based payment awards is calculated using the “treasury stock method,” which assumes that the “proceeds” from the exercise of these instruments are used to purchase common shares at the average market price for the period. The dilutive effect of convertible securities is calculated using the “if-converted method.” Under the if-converted method, securities are assumed to be converted at the beginning of the period, and the resulting shares of common stock are included in the denominator of the diluted calculation for the entire period being presented.

 

For the six months ended June 30, 2026 and 2025, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive.

          
   June 30,   June 30, 
   2026   2025 
   Shares   Shares 
Convertible notes       2,037,821 
Common Stock warrants   2,754,641    1,897,521 
Series C Convertible Preferred Stock   707,163    6,788,357 
    3,461,804    10,723,699 

 

Stock-Based Compensation

 

The Company accounts for employee and non-employee stock awards under ASC 718, Compensation – Stock Compensation, whereby equity instruments issued to employees for services are recorded based on the fair value of the instrument issued and those issued to nonemployees are recorded based on the fair value of the consideration received or the fair value of the equity instrument, whichever is more reliably measurable. Equity grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service.

 

During the three and six months ended June 30, 2026 and 2025, stock-based compensation was recognized as follows: 

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Management compensation  $1,302,667   $1,867,669   $3,418,845   $2,288,389 
Professional fees   282,997    19,000    443,377    264,420 
Professional fees - related party               2,103,600 
Financing expense               6,167,334 
Financing expense - related party   361,801    2,511,855    361,801    2,511,855 
 Stock-based compensation  $1,947,465   $4,398,524   $4,224,023   $13,335,598 

 

 

 

 14 

 

 

Compensation cost for stock awards, which include common shares, Series C Convertible Preferred Stock, warrants and performance stock units (“PSUs”), is measured at the fair value on the grant date and recognized as expense, net of estimated forfeitures, over the related service or performance period. The fair value of stock awards is based on the quoted price of our common stock on the grant date and Series C Convertible Preferred stock as if converted to common stock. We measure the fair value of PSUs using a Monte Carlo valuation model and warrants using a Black Scholes valuation model. Compensation cost for PSUs are recognized using the derived service period and accelerated if the condition is satisfied at an earlier date.

 

Recently Issued Accounting Pronouncements

 

In November 2024, the FASB issued ASU 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, requiring public entities to disclose additional information about specific expense categories in the notes to the financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of this standard on our disclosures.

 

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements, which clarifies the guidance in Topic 270 to improve the consistency of interim financial reporting. The ASU provides a comprehensive list of required interim disclosures and introduces a disclosure principle requiring entities to disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2025-11.

 

In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

Recently adopted accounting pronouncement

 

In July 2025, the FASB issued ASU No. 2025-05, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments in this update provide a practical expedient permitting an entity to assume that conditions at the balance sheet date remain unchanged over the life of the asset when estimating expected credit losses for current classified accounts receivable and contract assets. This update is effective for annual periods beginning after December 15, 2025, including interim periods within those fiscal years. The Company adopted ASU 2025-05, as of January 1, 2026, and applied the new disclosure requirements prospectively to the current annual period. The adoption of this ASU did not have an impact on our consolidated financial statements.

 

 

 

 

 15 

 

 

Note 3 – Inventory

 

As of June 30, 2026 and December 31, 2025, inventory consisted of the following: 

          
   June 30,   December 31, 
   2026   2025 
Finished goods  $75,076   $185,310 
Raw materials   504,049    435,458 
Inventory  $579,125   $620,768 

 

The Company did not write-off any inventories as unsalable for the six months ended June 30, 2026 and 2025.

 

Note 4 – Prepaid expenses

 

As of June 30, 2026 and December 31, 2025, prepaid expenses consisted of the following: 

          
   June 30,   December 31, 
   2026   2025 
Insurance  $115,369   $180,970 
Legal retainer   5,000     
Research and development expense   112,290     
Advertising and marketing   42,000    18,345 
Other prepaid operating expenses   131,219    94,705 
Deposit on purchase of inventories   12,926    23,000 
 Prepaid expenses  $418,804   $317,020 

 

Note 5 – Equipment, net

 

As of June 30, 2026 and December 31, 2025, equipment consisted of the following:

          
   June 30,   December 31, 
   2026   2025 
Cost:          
Equipment  $52,625   $43,396 
Vehicles   574,069    686,434 
Equipment gross   626,694    729,830 
Less: accumulated depreciation   (142,644)   (99,551)
Equipment, net  $484,050   $630,279 

 

 

 

 16 

 

 

During the three and six months ended June 30, 2026 and 2025, the Company recorded depreciation as follows.

                
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Depreciation  $28,385   $15,124   $58,604   $27,680 

 

During the six months ended June 30, 2026, the Company purchased equipment for $10,727. During the six months ended June 30, 2025, the Company purchased vehicles and equipment for $381,817, of which $118,776 were purchased with a financing loan, and transferred vehicles from inventory of $74,827 due to a change of use in 2025.

 

During the six months ended June 30, 2026, the Company sold and disposed of vehicles and equipment with a net book value of $98,353. In connection with these dispositions, the Company received cash from sale of equipment of $12,500, settled the related finance loan of $67,725 and paid $15,051 for settlement of finance loan, and settled other current liability of $922, resulting in a loss on disposal of $32,257.

 

Financing loan

 

The Company had a financing loan for the purchase of vehicle in September 2025. The loan repayment is $2,021 per month for 60 months, beginning October 2025, with an interest rate of 11.33%.

 

The Company had a financing loan for the purchase of vehicle in September 2025. The loan repayment is $2,083 per month for 48 months, beginning October 2025, with an interest rate of 11.90%. In June 2026, the Company sold the vehicle with a net book value of $83,489 and paid $15,051 to settle finance loan of $67,725. As a result, the Company recorded loss on disposal of $30,815.

 

During the three and six months ended June 30, 2026 and 2025, the Company recorded interest expense as follows:

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Interest expense  $3,569   $   $7,997   $4,427 

 

As of June 30, 2026 and December 31, 2025, the Company had a financing loan of $81,113 and $163,381, respectively.

 

Note 6 – Intangible Assets, net

 

In 2022, the Company acquired the intellectual property of Mighty Fire Breaker LLC (“MFB California”), 19 patents centered around its MFB Technology for the prevention and spread of wildfires. The granted patents include MFB California’s main chemistry and applications. MFB California had 21 trademarks and various copyrights. Internally generated patents, trademarks and copyrights, are expensed as incurred.

 

 

 

 17 

 

 

In December 2025, the Company entered into an Intellectual Property Purchase Agreement to protect our existing patents. The purchase price is $100,000 in cash and 220,000 shares of Common stock valued at $1,775,400, which shall be issued within 30 days of the closing date. The common stock was issued in January 2026.

 

As of June 30, 2026 and December 31, 2025, finite lived intangible assets consisted of the following:

          
   June 30,   December 31, 
   2026   2025 
Acquired patents (19)  $4,195,353   $4,195,353 
Patent and technology assets   1,243,000    1,243,000 
Non-compete agreements   632,400    632,400 
Accumulated amortization   (934,723)   (743,793)
Intangible assets, net  $5,136,030   $5,326,960 

 

Estimated future amortization expense for finite lived intangibles are as follows:

     
Year ending December 31,    
2026 (remaining six months)  $190,958 
2027   381,888 
2028   381,888 
2029   381,888 
2030   381,888 
Thereafter   3,417,520 
Intangible assets, net  $5,136,030 

 

As of June 30, 2026, the weighted-average useful life is 13.59 years.

 

During the three and six months ended June 30, 2026 and 2025, the amortization expense was as follows:

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Amortization  $95,465   $61,983   $190,930   $123,966 

 

Note 7 – Lease

 

In March 2022, the Company entered into an operating lease for a warehouse, with a term of eighteen (18) months. In July 2023, the Company amended the contract and extended the lease term to July 2025. In May 2025, the Company terminated this lease and wrote off the right-of-use asset and lease liability.

 

In January 2025, the Company entered into an operating lease for our office and warehouse. The commencement date was April 1, 2025, and the termination date is March 31, 2030. The Company recorded a security deposit of $36,991.

 

 

 

 18 

 

 

For the three and six months ended June 30, 2026 and 2025, the components of lease expense were as follows:

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
                 
Operating lease cost  $51,379   $65,811   $102,758   $87,309 
Short-term lease cost   11,768    4,553    19,541    34,146 
Variable lease cost   2,128    10,472    19,497    13,204 
Total lease cost  $65,275   $80,836   $141,796   $134,659 

 

Supplemental cash flow information related to leases was as follows:

          
   Six months ended 
   June 30, 
   2026   2025 
Cash paid for operating cash flows from operating leases  $96,757   $106,164 
Right-of-use asset obtained in exchange for new operating lease liabilities  $   $865,218 
           
Weighted-average remaining lease term - operating leases (year)   3.75    4.75 
Weighted-average discount rate — operating leases   7.00%    7.00% 

 

The following table outlines maturities of our lease liabilities as of June 30, 2026:

     
Year ending December 31,    
2026 (remaining six months)  $98,654 
2027   203,228 
2028   211,357 
2029   219,812 
2030   55,486 
Operating leases, future minimum payments due   788,537 
Less: Imputed interest   (94,886)
Operating lease liabilities  $693,651 

 

 

 

 

 19 

 

 

Note 8 – Convertible Notes

 

The components of convertible notes as of June 30, 2026 and December 31, 2025, were as follows:

                       
   Principal      Effective
Interest
   Stated
Interest
   June 30,   December 31, 
Payment date  Amount   Maturity date  Rate   Rate   2026   2025 
February 15, 2025  $575,000   February 15, 2026  510%   10%   $   $375,000 
Total Convertible notes                       375,000 
Less: Unamortized debt discount                       (155,679)
                        219,321 
Less: Current portion                       (219,321)
Long-term portion                  $   $ 

 

During the three and six months ended June 30, 2026 and 2025, the Company recognized interest expense and amortization of debt discount as follows:

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Interest expense  $   $76,673   $4,726   $136,931 
Amortization of debt discount  $   $475,166   $155,679   $820,994 

 

As of June 30, 2026 and December 31, 2025, the Company recorded accrued interest of $0 and $32,773, respectively.

  

Conversion

 

In February 2026, seven (7) note holders converted convertible notes issued in February 2025 of $375,000 and accrued interest of $37,500 into 171,878 shares of common stock with a conversion price of $2.40. As a result, the Company settled convertible notes and accrued interest of $412,500, and recorded loss on settlement of debt of $847,366.

 

Note 9 – Accounts payable and accrued liabilities

 

As of June 30, 2026 and December 31, 2025, accounts payable and accrued liabilities consisted of the following:

          
   June 30,   December 31, 
   2026   2025 
Accounts payable  $198,361   $169,278 
Accrued interest       32,773 
Credit card   7,467    19,953 
Sales tax payable   3,072    27,675 
Other liabilities   1,374    53,280 
Payroll liability   11,546    13,362 
Accounts payable and accrued liabilities  $221,820   $316,321 

 

 

 

 20 

 

 

Note 10 – Related Party Transactions

 

The related parties that had material transactions for the six months ended June 30, 2026 and 2025, consist of the following: 

Related Party   Nature of Relationship to the Company
A   An Ohio Corporation - a significant shareholder
B   Owner of A and our Chairman of the Board
C   A California Corporation owned by a related party D
D   Significant shareholder and our Chief Technology Officer through March 31, 2026
E   Former Director and Chief Executive Officer of GEVI Insurance Holdings Inc.
F   A Delaware limited liability company controlled by a Director and significant shareholder
G   A company controlled by our Chief Financial Officer

 

As of June 30, 2026 and December 31, 2025, amounts owing to related parties consists as follows:

             
   June 30,   December 31,    
Related Party  2026   2025   Nature of transaction
A  $300   $300   Operating expenses paid on behalf of the Company
F       167,671   Accrued interest related to convertible note related party
G   4,900       Consulting fees
   $5,200   $167,971    

 

For the three and six months ended June 30, 2026 and 2025, expenses to related parties and their nature consists of:

   Three Months Ended       
   June 30       
Related Party  2026   2025   Nature of transaction  Financial Statement Line Item
A  $   $25,300   Payment of operating expenses on behalf of the Company  Due to related party
A  $   $25,000   Repayment of loan  Due to related party
C  $   $5,600   Cash paid for consulting fees  Professional fees - related party
D  $   $35,000   Cash paid for royalty and sales commissions  Cost of revenue - related party
D  $30,000   $   Cash paid for consulting fees  Professional fees - related party
F  $   $2,511,855   69,007 Series C preferred stock for services  Financing expense
G  $13,150   $   Professional service - accounting  Professional fees - related party

 

 

 

 

 21 

 

 

   Six Months Ended       
   June 30       
Related Party  2026   2025   Nature of transaction  Financial Statement Line Item
A  $   $2,103,600   150,000 Series C preferred stock for consulting fee  Professional fees - related party
A  $   $25,300   Payment of operating expenses on behalf of the Company  Operating expenses
A  $   $25,000   Repayment of loan  Due to related party
C  $   $21,600   Cash paid for consulting fees  Professional fees - related party
C  $   $4,000   Cash paid for consulting and advisory fees  Cost of revenue - related party
D  $   $91,290   Cash paid for royalty and sales commissions  Cost of revenue - related party
D  $30,000   $   Cash paid for consulting fees  Professional fees - related party
E  $   $420,720   30,000 Series C preferred stock for management compensation  Management compensation
E  $   $   20,000 shares of Series C preferred stock for advisory fee  Professional fees - related party
F  $   $2,511,855   69,007 Series C preferred stock for services  Financing expense
G  $5,505   $   Edgar filing expense  General and administrative
G  $37,660   $   Professional service - accounting  Professional fees - related party

 

Contributed Capital

 

In February 2026, the Company received payments from related party B, totaling $96,258 related to disgorgement of short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Company recognized these proceeds as a capital contribution and the amounts were recorded as an increase to additional paid-in capital on the unaudited interim consolidated balance sheets.

 

Convertible note – related party

 

The components of convertible notes as of June 30, 2026 and December 31, 2025, were as follows:

                          
          Effective   Stated         
   Principal      Interest   Interest   June 30,   December 31, 
Payment date  Amount   Maturity date  Rate   Rate   2026   2025 
February 2025  $2,222,000   April 28, 2026  16.25%   10%   $   $2,000,000 
Total Convertible notes                  $   $2,000,000 
Less: Unamortized debt discount                       (714,600)
                        1,285,400 
Less: Current portion                       (1,285,400)
Long-term portion                  $   $ 

 

 

 

 

 22 

 

 

In February 2025, the Company entered into one (1) subscription agreement for convertible note ($2,000,000) and warrants (416,667 shares of common stock) with related party F. The convertible note has a term of twelve (12) months, at an interest rate of 10% per annum and warrants are with a term of five (5) years, at exercise price of $3.00 per share. The outstanding principal amount of convertible note and unpaid interest is convertible at a fixed conversion price of $2.40. The obligations of the Company under the convertible note are secured by a pledge of the Company’s membership interests in MFB Ohio. In the event of a default, related party F could proceed against the equity of MFB Ohio pledged to collateralize the convertible note. MFB Ohio owns the Company’s intellectual property portfolio. On February 27, 2026, related party F extended their convertible promissory note until April 28, 2026. Pursuant to the extension, they charged a 1% amendment fee and agreed to release their security pledge against certain intangible assets of the Company. As a result, the principal amount became $2,222,000, including accrued interest of $200,000 and 1% fee of $22,000.

 

The Company evaluated the modification of terms under ASC 470-50, “Debt - Modification and Extinguishment”, and concluded that the extension of the maturity dates did not result in a substantial change and consequential changes to the economic substance of the debt and thus resulted in a modification of the debt and not extinguishment of the debt. Accordingly, no gain or loss on debt extinguishment was recorded.

 

During the three and six months ended June 30, 2026 and 2025, the Company recognized interest expense and amortization of debt discount as follows:

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Interest expense - related party  $17,046   $64,241   $68,246   $95,447 
Amortization of debt discount - related party  $10,516   $148,546   $736,600   $179,396 

 

Conversion

 

In April 2026, related party F converted a convertible note with accrued interest of $35,917 into 940,799 shares of common stock with a conversion price of $2.40.

 

As of June 30, 2026 and December 31, 2025, the Company recorded accrued interest of $0 and $167,671, respectively.

 

Note 11 – Stockholders’ Equity

 

Preferred Stock

 

Shares Outstanding

 

The Company is authorized to issue up to 30,000,000 shares of Preferred Stock, par value $0.0001 per share.

 

Series A Preferred Stock

 

The Company designated 10,000,000 shares of its Preferred Stock as Series A Preferred Stock, par value $0.0001, with the following rights and privileges.

 

Dividends. Holders of shares of Series A Preferred Stock are not entitled to receive dividends.

 

 

 

 23 

 

 

Voting Rights. Each share of Series A Preferred Stock is entitled to 1,000 votes on all matters submitted to a vote of the holders of Common Stock, voting together with the holders of Common Stock as a single class. Holders of shares of Series A Preferred Stock do not have cumulative voting rights. This means a holder of a single share of Series A Preferred Stock cannot cast more than one vote for each position to be filled on the Board of Directors.

 

Other Rights. Shares of Series A Preferred Stock are not entitled to a liquidation preference. The holders of the Series A Preferred Stock may not be redeemed without the consent of the holders of the Series A Preferred Stock. The holders of the Series A Preferred Stock are not entitled to pre-emptive rights or subscription rights.

 

Share exchange

 

On May 28, 2026, the Company entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock. Pursuant to the Exchange Agreements, the Company reacquired an aggregate of 1,666,667 shares of Series A Preferred Stock. At closing, the Company issued 103,558 shares of Series C Convertible Preferred Stock to BoltRock Holdings, LLC (“BRH”), and agreed to issue 467,012 shares of Series C Preferred Stock to TC Special Investments LLC (“TCSI”) on the date that is 18 months after closing, unless issued earlier in connection with a change of control of the Company which, under the TCSI Exchange Agreement, includes the appointment of Theodore S. Ralston to the Company’s board of directors (collectively, the “Exchange Shares”). As a result, the Company recorded the 103,558 shares of Series C Preferred Stock issued to BRH, and the Series C Preferred Stock payable representing the 467,012 shares to be issued to TCSI, as additional paid-in capital.

 

As of June 30, 2026 and December 31, 2025, there were 0 and 1,666,667, respectively, shares of Series A Preferred stock issued and outstanding.

 

Series C Convertible Preferred Stock

 

The Company has designated 10,000,000 shares of its Preferred Stock as Series C Convertible Preferred Stock with the following rights and privileges.

 

Dividends. Holders of shares of Series C Convertible Preferred Stock are not entitled to receive dividends.

 

Voting Rights. The holders of the Series C Convertible Preferred Stock are not entitled to vote.

 

Conversion Rights. Each share of Series C Convertible Preferred Stock outstanding shall be convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into 3.3333 shares of the Common Stock of the Company (the “Conversion Ratio”). Such Conversion Ratio, and the rate at which shares of Series C Convertible Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment.

 

Other Rights. The holders of the Series C Convertible Preferred Stock are not entitled to a liquidation preference. The holders of the Series C Convertible Preferred Stock may not be redeemed without the consent of the holders of the Series C Convertible Preferred Stock. The holders of the Series C Convertible Preferred Stock are not entitled to pre-emptive rights or subscription rights.

  

During the six months ended June 30, 2026, the Company issued 103,558 shares of Series C Convertible Preferred Stock to BRH and 467,012 shares to be issued to TCSI.

 

 

 

 24 

 

 

During the six months ended June 30, 2025, the Company issued 344,007 shares of Series C Convertible Preferred Stock as follows:

 

·27,500 shares for purchase subscriptions of $260,000, at prices of $4.00 or $6.00 per share
·236,507 shares for services, valued at $4,860,875 at market price on issuance dates.
·80,000 shares for compensation, valued at $1,520,720 at market price on issuance dates.

 

During the six months ended June 30, 2026, the holders of the Convertible Series C Preferred Stock converted 699,077 shares of the Company’s Convertible Series C Preferred Stock into 2,330,273 shares of the Company’s common stock, respectively.

 

As of June 30, 2026 and December 31, 2025, there were 212,149 and 807,668 shares of the Company’s Series C Convertible Preferred Stock issued and outstanding, respectively.

 

Common Stock

 

The Company has authorized 1,000,000,000 shares of common stock with a par value of $0.0001. Each share of common stock entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought.

 

During the six months ended June 30, 2026, the Company issued 3,990,659 shares of Common Stock as follows:

 

·2,330,273 shares for conversion of 699,077 shares of Series C Preferred Stock
·1,112,677 shares for conversion of debt of $3,517,783
·55,333 shares for service, valued at $443,377
·189,042 shares for cash and cashless exercise of warrants, for cash proceeds of $25,002
·220,000 shares for stock payable for acquisition of IP, valued at $1,775,400, which was recorded as additional paid in capital as of December 31, 2025. 
·83,334 shares for management compensation valued at $566,672

 

During the six months ended June 30, 2025, the Company issued 29,245,272 shares of common stock as follows:

 

  · 26,189,380 shares for conversion of Series C Preferred Stock.
  · 3,045,892 shares for conversion of debt of $5,604,442.
  · 10,000 shares for services, valued at $19,000.

 

As of June 30, 2026 and December 31, 2025, there were 22,512,974 and 18,522,315 shares of the Company’s common stock issued and outstanding, respectively.

 

Restricted stock units (RSU)

 

On June 27, 2025 (the “Effective Date”), the Company entered into the employment agreement with our Chief Operating Officer (“COO”), commencing on July 21, 2025. Under this agreement, the Company issued 150,000 restricted shares of the Common Stock as stock bonus. Shares shall vest one-fourth each anniversary of the Effective Date. The grant date fair value of shares is $1,799,970.

 

 

 

 25 

 

 

On September 22, 2025, the Company entered into the employment agreement with our new Chief Executive Officer (“CEO”), commencing on October 1, 2025 (the “Effective Date”). Under this agreement, the Company issued 300,000 restricted shares of the Common Stock as stock bonus. Shares shall vest one-fourth on first anniversary of the Effective Date and the remaining three-fourths on monthly basis over the following 36 months. The grant date fair value of shares is $1,698,000.

 

During the three and six months ended June 30, 2026, the Company recorded compensation expense of $218,623 and $437,246, respectively. As of June 30, 2026, unrecognized compensation cost for unvested equity awards was $2,729,603.

 

Management stock compensation (PSU)

 

During 2025, the Company entered into employment and consulting agreements with our CEO, former CEO, COO and a Director. The stock compensation based on market capitalization condition is as follows:

Market

capitalization for

30 consecutive days

 

Consulting agreement Former

CEO and Chairman

 

Consulting agreement

Chairman

 

Employment

agreement COO

 

Employment

agreement CEO

$ 120,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock    
$ 150,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   37,500 common stock   75,000 common stock
$ 200,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   37,500 common stock   75,000 common stock
$ 250,000,000   70,000 Series C Convertible Preferred Stock   70,000 Series C Convertible Preferred Stock   37,500 common stock   75,000 common stock
$ 300,000,000       37,500 common stock   75,000 common stock
                   
  Fair value ($)   1,932,000   3,165,000   1,740,000   1,580,000
  Forfeiture Protection   Vests upon completion of Initial Term; awards survive termination   Vests upon completion of Initial Term; awards survive termination   Forfeited if terminated for cause or resignation   Forfeited if terminated for cause or resignation

 

The Company used the Monte Carlo model to calculate the fair value of compensation and estimated a total of the grant date fair value of $8,417,000. The Company records compensation expense over the term of a derived service period unless the condition is satisfied at an earlier date. During the three and six months ended June 30, 2026, the Company recorded compensation expense of $517,372 and $2,414,927, respectively. As of June 30, 2026, unrecognized compensation cost for unvested equity awards was $192,671 which is expected to be recognized over a remaining weighted-average period of 0.24 years.

 

As of June 30, 2026, market capitalization performance conditions had been achieved with respect to certain outstanding equity incentive awards. Theodore Ralston, the Company’s former Chief Executive Officer, and BoltRock Holdings, LLC, a Company controlled by the Company’s Chairman, each became eligible to receive 140,000 shares of Series C Convertible Preferred Stock, but each has elected to defer receipt of such shares. In addition, Wesley Bolsen, the Company’s Chief Executive Officer, and Andrew Hotsko, the Company’s Chief Operating Officer, became eligible to receive 75,000 and 37,500 shares of common stock, respectively, subject to approval by the Compensation Committee. No shares underlying these awards had been issued as of June 30, 2026.

 

 

 

 26 

 

 

For the year ended December 31, 2025, the estimated fair values of the awards were measured using the following significant assumptions: 

       
Derived service period     0.51 - 1.05 year  
Risk-free interest rate     3.62% - 3.97%  
Stock price at valuation date   $ 5.66 - 12.00  
Expected average volatility     108.5% - 151.0%  
First Capitalization Threshold per share price   $ 6.85 - 14.28  
Second Capitalization Threshold per share price   $ 8.56 - 19.02  
Third Capitalization Threshold per share price   $ 11.42 - 23.82  
Fourth Capitalization Threshold per share price   $ 14.27 - 28.56  

 

Warrants

 

In April 2026, the Company issued 46,250 warrants to a related party F for services. The warrant is for a period of five years at an exercise price per share of $3.00. The Company recorded the warrants value of $361,801 to additional paid-in capital.

 

We evaluate all warrants issued to determine the appropriate classification under ASC 480 and ASC 815. In addition to determining classification, we evaluate these instruments to determine if such instruments meet the definition of a derivative. The classification of all outstanding warrants, including whether such instruments should be recorded as equity, is evaluated at the end of each reporting period.

 

The warrants are valued using a Black Scholes valuation model. The use of this valuation model requires the input of highly subjective assumptions. Any change to these inputs could produce significantly higher or lower fair value measurements.

 

The Company utilized the following assumptions: 

     
   June 30, 
   2026 
Expected term   5.00 years 
Expected average volatility   89% 
Risk-free interest rate   3.95% 
Expected dividend yield    

 

 

 

 

 27 

 

 

A summary of activity of the warrants during the six months ended June 30, 2026 is as follows:

               
   Warrants Outstanding     
       Weighted Average   Weighted Average Remaining Contractual Life 
   Shares   Exercise Price   (in years) 
                
Outstanding, December 31, 2025   2,909,434   $3.66    4.37 
Granted   46,250    3.00    5.00 
Exercised   (201,043)   0.56     
Outstanding, June 30, 2026   2,754,641   $3.67    3.88 
                
Exercisable, June 30, 2026   2,421,307   $4.41    3.94 

 

The intrinsic value of the warrants as of June 30, 2026 is approximately $5.0 million.

 

Note 12 – Disaggregated revenue and Concentration

 

During the three and six months ended June 30, 2026 and 2025, disaggregated revenue was as follows:

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Products sale  $205,673   $446,785   $409,069   $1,051,267 
Product installation service   74,993    240,853    216,512    605,753 
   $280,666   $687,638   $625,581   $1,657,020 

 

During the three and six months ended June 30, 2026 and 2025, customer and supplier concentrations (more than 10%) were as follows:

 

 

 

 

 

 28 

 

 

Revenue and accounts receivable

 

Recurring customers do not represent a material percentage of our revenue for the three and six months ended June 30, 2026 and 2025 and accounts receivable as of June 30, 2026 and December 31, 2025.

                    
   Three months ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
Number of customers (more than 10% of revenue)   3    3    3    1 
Total revenue of top 5 customers   71.9%    78.4%    52.5%    40.7% 

 

   June 30,   December 31, 
   2026   2025 
Number of customers (more than 10% of accounts receivable)   4    3 
Total % of accounts receivable balance (more than 10%)   89.9%    61.1% 

 

Purchase and accounts payable for Inventory

                              
   Percentage of Purchases   Percentage of Purchases   Percentage of 
   For three months ended   For six months ended   Accounts payable for purchase 
   June 30,   June 30,   June 30,   December 31 
   2026   2025   2026   2025   2026   2025 
Supplier A       25.1%    73.0%    36.5%        98.8% 
Supplier B   28.9%    6.2%    5.3%    5.0%        1.2% 
Supplier C   12.2%        1.9%             
Supplier D   57.6%        12.2%    3.6%         
Supplier E               15.2%         
Supplier F       43.1%        19.8%         
Total (as a group)   98.7%    74.4%    92.4%    80.1%        100.0% 

 

To reduce risk, the Company closely monitors the amounts due from its customers and assesses the financial strength of its customers through a variety of methods that include, but are not limited to, engaging directly with customer operations and leadership personnel, visiting customer locations to observe operating activities, and assessing customer longevity and reputation in the marketplace. As a result, the Company believes that its accounts receivable credit risk exposure is limited.

 

 

 

 

 29 

 

 

Note 13 – Segment

 

Our Chief Executive Officer (“CEO”) is the chief operating decision maker who reviews financial information on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, we determined we operate in a single reporting segment - environmentally sustainable specialty chemicals for fire prevention and protection in the lumber and wood products, wildland fire and residential home industry.

 

Our CEO assesses performance and decides how to allocate resources primarily based on consolidated net income, which is reported on our Consolidated Statements of Operations. Total assets on the Consolidated Balance Sheets represent our segment assets.

                    
   Three Months Ended   Six months ended 
   June 30,   June 30, 
   2026   2025   2026   2025 
                 
Revenue  $280,666   $687,638   $625,581   $1,657,020 
                     
Operating expenses                    
Cost of revenue, exclusive of amortization and depreciation shown separately below   271,628    371,392    497,205    928,362 
Cost of revenue - related parties               60,290 
Amortization and depreciation   123,850    77,107    249,534    151,646 
General and administrative   218,290    270,227    628,246    473,398 
Advertising and marketing   210,792    152,608    348,392    257,104 
Payroll and management compensation   2,061,328    2,334,698    5,168,695    3,008,121 
Professional fees   648,710    445,668    1,328,552    1,072,986 
Professional fees - related parties   43,150    12,300    67,660    2,131,900 
Research and development expense   197,067    41,276    278,592    49,307 
Total operating expenses   3,774,815    3,705,276    8,566,876    8,133,114 
                     
Loss from operations   (3,494,149)   (3,017,638)   (7,941,295)   (6,476,094)

 

   June 30,   December 31, 
   2026   2025 
Total Assets  $10,036,040   $14,183,519 

 

Note 14 – Subsequent Events

 

Management has evaluated subsequent events through August 7, 2026, which is the date these financial statements were available to be issued. Based on our evaluation, no material events have occurred that require disclosure, except as follows:

 

·Issuance of 37,500 common shares to our COO for RSU vesting
·Issuance of 3,000 common shares to a consultant valued at $16,800

 

 

 

 30 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (the “Quarterly Report”) contains forward-looking statements. The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management’s plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will” and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated sales efforts, expenses, the outcome of contingencies, such as legal proceedings, and financial results.

 

We caution that the factors described herein, and other factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

 

Our unaudited financial statements are stated in United States Dollars (USD) and are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this Quarterly Report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this Quarterly Report.

 

In this Quarterly Report, unless otherwise specified, all dollar amounts are expressed in United States Dollars.

 

As used in this Quarterly Report, the terms “we”, “us”, “our” and “our company” mean CitroTech Inc.

 

Overview

 

We are a specialty chemical company focused on environmentally friendly fire inhibitor products serving the wildland fire, residential and commercial property protection, and wood products industries across the United States and Canada. Our fire inhibitor formulations are also used by the lumber and building materials industry for fire retardant treatment applications.

 

The Company’s management team is highly experienced at building and running companies, as well as commercializing and executing on strategic partnerships for the sale of products and services.

 

Since Mighty Fire Breaker LLC (“MFB Ohio”) acquired from Mighty Fire Breaker LLC (“MFB California”) the MFB portfolio of intellectual property on April 13, 2022, our management team has continued to develop and refine our product formulations. The Company has received significant third-party recognition for these efforts, including twice receiving the EPA Safer Choice designation. Our product is the first and only fire inhibitor recognized by the EPA as safe for the environment. We also are the first fire inhibitor to receive UL GREENGUARD Gold certification, which reflects minimal impact on indoor air quality from toxic smoke over extended exposure. Our products have been adopted by fire departments throughout the State of California.

 

 

 

 31 

 

 

CitroTech has been issued 31 patents and has 56 patents pending. We are expanding our patent portfolio and technology platform into additional markets that can benefit from environmentally safe alternatives to legacy fire retardant and fire retardant-treated wood products. Using this technology, CitroTech has developed products that help achieve Class-A fire rating for lumber and engineered wood products. We are in the initial phases of commercializing this product. In April 2026, CitroTech and Hexion Inc. formed a 50/50 global joint venture named HexiTech LLC, a Delaware limited liability company that will work to commercialize the CitroTech product into factory applied lumber and wood products. This venture will be the Company’s primary go-to-market channel for this portion of the business.

 

The Company is also actively deploying proactive wildfire defense systems on residential and commercial properties under the CitroSafe Systems brand. CitroSafe Systems are self-contained sprinkler installations that utilize our patented CitroTech product. These systems deploy our fire inhibitor in advance of wildfires to help prevent the advance of fires and reduce structural risk. In addition to protecting property owners from the ravages of wildfires, this offering addresses a significant and growing insurance market disruption across the Western United States, where carriers have curtailed or declined to write wildfire coverage on new construction and are cancelling or not renewing existing policies in the Wildland-Urban Interface (“WUI”). WUI is the transitional zone between undeveloped land and built environments that is at elevated risk of catastrophic wildfire loss. The Company is working with a large insurance broker to offer insurance coverage to customers who install a CitroSafe proactive wildfire system, with policies underwritten by established insurance carriers. This program is currently in the proof-of-concept phase.

 

Our management team consists of four individuals: Wesley J. Bolsen, Chief Executive Officer; Andrew Hotsko, Chief Operating Officer; Nanuk Warman, Secretary and Chief Financial Officer; and Anthony Newton, General Counsel.

 

Known Trends and Uncertainties

 

Growth in Fire Safety

 

We believe that fire safety benefits from several growth drivers, including increasing fire severity, as measured by higher acres burned, longer fire seasons and a growing urban component moving into the WUI, resulting in increased demand for specialty chemical fire inhibitors, thereby increasing production. We believe these trends are prevalent in North America, as well as globally, and we expect these trends to continue driving growth in demand for fire retardants and fire retardant treated lumber products. We have expanded our certified partner network to more than 20 organizations in the second quarter of 2026 that will install systems and/or apply CitroTech product around homes and in the community.

 

We are working to grow our fire prevention and protection business, which is primarily focused on expanding use of ground-applications for long-term fire retardants. This growth includes use of ground assets in response to active fires (protection), as well as proactive treatments around critical infrastructure and known high-risk areas (prevention). Fire prevention products can be used to help prevent fire ignitions and protect property from potential fire danger by providing proactive retardant treatment in high-risk areas such as along roadsides, under power lines, along railroad rights-of-way, and around residential neighborhoods and commercial infrastructure. Treating these areas ahead of the fire season can help to prevent ignitions from equipment failures or sparks until a significant rainfall occurs. This prevention effort was proven by San Diego announcing an expansion of their CitroTech treatment program during 2026 based on success seen in 2025. Although there is no certainty in wildfire defense, when our CitroSafe system is installed, we fill it with our CitroTech product. Thereafter, we will conduct an annual inspection of the system to help ensure it is ready to help defend against a wildfire. While there is no specific useful life for our product, if the system has not been deployed since the third anniversary of the initial installation, or three years following an annual inspection, in an abundance of caution we will recommend the customer replace the CitroTech product. In addition, we suggest spraying CitroTech in areas surrounding the property that pose the greatest risk to help reduce the risk posed by dry vegetation, decks, garden bark, and fences. 

 

We have invested and intend to continue investing in the expansion of our fire retardant and lumber treatment business through product development and business development to grow our customer base.

 

 

 

 32 

 

 

Weather Conditions and Climate Trends

 

Our business is highly dependent on the needs of commercial entities, residential homeowners and fire departments to prevent fires and protect assets, as well as the use and expansion of Class A Fire Retardant Treated lumber and wood products. As such, our financial condition and results of operations are significantly impacted by weather, which impact the number and severity of fires in any given year. Typically, sales of our product are higher during the summer months in the United States due to weather patterns that are generally correlated to a higher prevalence of wildfires due to drought. We believe orders will generally peak during the late summer months, but with expanded fire seasons in the United States, ignitions may continue through late fall or even into the winter months.

 

Results of Operations

 

We are developing and commercializing our product lines. We have been focused historically on obtaining patents and various accreditations. To date, we do not have a large customer base, having relied heavily on a few customers, for the commercialization and testing of our CitroTech product and delivery system. We currently do not have an established retail product line nor recurring significant customer base. 

 

The following summary of our results of operations should be read in conjunction with our unaudited financial statements for six months ended June 30, 2026 and 2025, which are included herein.

  

Our results of operations for the three months ended June 30, 2026 and 2025 are summarized below:

 

   Three Months Ended         
   June 30,         
   2026   2025   Change   % 
Revenue  $280,666   $687,638   $(406,972)   (59%)
Operating expenses   3,774,815    3,705,276    69,539    2% 
Other expense   408,405    8,886,380    (8,477,975)   (95%)
Net loss  $(3,902,554)  $(11,904,018)  $(8,001,464)   (67%)

 

Revenue

 

Our revenue is generated through our subsidiary Mighty Fire Breaker LLC ("MFB Ohio"), which acquired our fire suppression intellectual property portfolio in April 2022. Our revenue is highly seasonal and event-driven, with demand concentrated in the Western United States during the traditional May to October fire season, and is materially influenced by wildfire activity in any given period. During the three months ended June 30, 2026, revenue decreased $407,000, or 59%, compared to the three months ended June 30, 2025. The rare situation of a devastating fire in both the Pacific Palisades and Eaton Canyon, in the first quarter of 2025 added to system revenue in the first quarter of 2025 that was not seen in 2026. In addition, revenue that was booked in the first half of 2025 related to CitroSafe systems is being shifted to our Certified Partners for the installation of systems, with higher margin CitroTech chemical sales that are being put into the system mostly starting after the end of the second quarter. This strategic shift will drive the installation of more systems with more CitroTech product and recurring income in the future from a redeveloped control system. This accounts for some of the change in revenues from the prior year quarter. Although the 50/50 joint venture with Hexion was formed in Q2 2026, no revenues were generated from the joint venture in the early days of getting it established.

  

 

 

 33 

 

 

Our revenues consisted of the following:

 

   Three Months Ended 
   June 30, 
   2026   2025 
Products sale  $205,673   $446,785 
Product installation service   74,993    240,853 
   $280,666   $687,638 

 

Our revenues from significant customers for the three months ended June 30, 2026 and 2025, are as follows: 

 

   Three months ended 
   June 30, 
   2026   2025 
Number of customers (more than 10% of revenue)   3    3 
Total revenue of top 5 customers   71.9%    78.4% 

 

Our revenue is currently project- and event-driven rather than subscription- or contract-based, and we do not currently have a meaningful base of recurring customers. The decrease in our top-five customer concentration to 71.9% in the three months ended June 30, 2026, from 78.4% in the comparable 2025 period, reflects both the absence of the Pacific Palisades and Eaton Canyon fire deployments that drove revenue in the prior period and the early-stage nature of our commercial customer base. We expect customer concentration to remain elevated until our channel partner program and recurring utility and structural-protection customer relationships further mature.

 

Operating Expenses

 

   Three Months Ended         
   June 30,         
   2026   2025   Change   % 
Cost of revenue  $271,628   $371,392   $(99,764)   (27%)
Amortization and depreciation   123,850    77,107    46,743    61% 
General and administrative   218,290    270,227    (51,937)   (19%)
Advertising and marketing   210,792    152,608    58,184    38% 
Payroll and management compensation   2,061,328    2,334,698    (273,370)   (12%)
Professional fees   691,860    457,968    233,892    51% 
Research and development expense   197,067    41,276    155,791    377% 
Total operating expenses  $3,774,815   $3,705,276   $69,539    2% 

 

The increase in operating expenses was primarily attributed to increases in professional fees, research and development costs, and advertising and marketing, partially offset by decreases in management compensation and cost of revenue.

 

 

 

 34 

 

 

Cost of revenue

 

   Three Months Ended         
   June 30,         
   2026   2025   Change   % 
Cost of inventory  $207,418   $304,791   $(97,373)   (32%)
Freight and shipping   5,629    5,899    (270)   (5%)
Rent expense   58,581    60,702    (2,121)   (3%)
Total cost of revenue  $271,628   $371,392   $(99,764)   (27%)

 

During the three months ended June 30, 2026, the cost of revenue decreased over the three months ended June 30, 2025, primarily due to a decrease in cost of inventory.

 

Cost of inventory consists of product costs, direct labor, related supplies, and direct testing of our CitroTech product and the various components required for installation of CitroSafe™ systems. Cost of inventory decreased during the three months ended June 30, 2026, compared to the comparable 2025 period, primarily due to lower product sales volume.

 

Freight and shipping relate to costs for shipping products to customers.

 

Rent expenses are warehouse and facility rent expenses.

 

Amortization and depreciation

 

Amortization and depreciation expenses are from the amortization of patents and technology and the depreciation of vehicles, furniture and equipment.

 

General and administrative

 

General and administrative expenses are office, rent, travel, insurance, website, IT, public listing fees, and other office related expenses. For the three months ended June 30, 2026, we incurred decreased expenditures on our website and IT development and general office offset by an increase in insurance and public listing fees.

 

Advertising and marketing 

 

The increase in advertising and marketing during the three months ended June 30, 2026, over the three months ended June 30, 2025, is primarily due to supporting revenue growth in addition to investor relations activities after being uplisted to the NYSE American. This includes rebranding efforts around the official company name change to CitroTech Inc. from General Enterprise Ventures Inc as well as the product labels moving from Mighty Fire Breaker to CitroTech and the conversion of relevant website and marketing materials.

 

Professional fees

 

The professional fees during the three months ended June 30, 2026, primarily included stock-based compensation of $283,000 to advisors to our subsidiary MFB, and various professional fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2026. The professional fees during the three months ended June 30, 2025, did not include stock-based compensation. Professional fees were for accounting and audit related to SEC filings, legal on patents and other consulting services in 2025.

 

 

 

 35 

 

 

Payroll and management compensation

 

During the three months ended June 30, 2026, management compensation decreased to $2.1 million from $2.3 million in the prior period. This decrease was primarily attributable to the buildout of a full executive management team during 2025, including the appointment of a Chief Operating Officer, Chief Financial Officer, Chief Technology Officer, and General Counsel. Compensation during 2026 and 2025, primarily included stock-based management compensation of $1.3 million and $1.9 million, respectively. Payroll compensation to employees during 2026, was approximately $0.8 million as compared to $0.4 million during 2025.

 

Research and development costs


We continue to invest heavily in the testing and certifications of CitroTech treated products as well as in advance of submitting formulas for approval to apply product onto federal lands. We are spending on outside testing to ensure that our products can pass the rigorous US Forest Service QPL testing as well as funding an additional product to be submitted to the US Forest Service for testing. We expect to continue growing R&D spend over historical spend as we add additional product lines and invest in the future of the company. This includes funded research programs with Texas A&M on new products that were not underway in 2025.

 

Other Expenses

 

For the three months ended June 30, 2026 and 2025, the other expenses consisted of interest expense primarily related to convertible notes payable issued in 2025 of $31,000 and convertible notes payable issued in 2025 and 2024 of $764,000, respectively, change in fair value of derivative liability related to convertible notes payable issued in 2025 and 2024 of $0 and $3.0 million, respectively, financing expense of $361,000 and $2.5 million, respectively, and loss on settlement of debt of $0 and $2.6 million, respectively. Settlement of debt in 2025 was the conversion of convertible notes issued in 2024. Financing expense is from 69,007 shares of Series C Convertible Preferred stock issued to BoltRock Holdings, LLC (“BRH”) in 2025.

  

Net loss

 

The net loss for the three months ended June 30, 2026 was approximately $3.9 million, a decrease of approximately $8.0 million as compared to the three months ended June 30, 2025, primarily due to a significant reduction in other expenses, partially offset by lower revenue and higher operating expenses. 

 

Our results of operations for the six months ended June 30, 2026 and 2025 are summarized below:

 

   Six months ended         
   June 30,         
   2026   2025   Change   % 
Revenue  $625,581   $1,657,020   $(1,031,439)   (62%)
Operating expenses   8,566,876    8,133,114    433,762    5% 
Other expenses   2,171,823    16,331,328    (14,159,505)   (87%)
Net loss  $(10,113,118)  $(22,807,422)  $(12,694,304)   (56%)

 

 

 

 

 36 

 

 

Revenue

 

Our revenue is generated through our subsidiary Mighty Fire Breaker LLC ("MFB Ohio"), which acquired our fire suppression intellectual property portfolio in April 2022. Our revenue is highly seasonal and event-driven, with demand concentrated in the Western United States during the traditional May to October fire season, and is materially influenced by wildfire activity in any given period. During the six months ended June 30, 2026, revenue decreased $1.0 million, or 62%, compared to the six months ended June 30, 2025. The rare situation of a devastating fire in both the Pacific Palisades and Eaton Canyon in the first six months of 2025 added to system revenue in the first half of 2025 that was not seen in the first half of 2026.

  

Our revenues consisted of the following:

 

   Six months ended 
   June 30, 
   2026   2025 
Products sale  $409,069   $1,051,267 
Product installation service   216,512    605,753 
   $625,581   $1,657,020 

 

Our revenues from significant customers for the six months ended June 30, 2026 and 2025, are as follows: 

 

   Six months ended 
   June 30, 
   2026   2025 
Number of customers (more than 10% of revenue)   3    1 
Total revenue of top 5 customers   52.5%    40.7% 

 

Our revenue is project- and event-driven rather than subscription- or contract-based, and we do not currently have a meaningful base of recurring customers. The increase in our top-five customer concentration to 52.5% in the six months ended June 30, 2026, from 40.7% in the comparable 2025 period, reflects both the absence of the Pacific Palisades and Eaton Canyon deployments that drove revenue in the prior period and the early-stage nature of our commercial customer base. We expect customer concentration to remain elevated until our channel partner program and recurring utility and structural-protection customer relationships further mature.

 

Operating Expenses

 

   Six months ended         
   June 30,         
   2026   2025   Change   % 
Cost of revenue  $497,205   $988,652   $(491,447)   (50%)
Amortization and depreciation   249,534    151,646    97,888    65% 
General and administrative   628,246    473,398    154,848    33% 
Advertising and marketing   348,392    257,104    91,288    36% 
Payroll and management compensation   5,168,695    3,008,121    2,160,574    72% 
Professional fees   1,396,212    3,204,886    (1,808,674)   (56%)
Research and development expense   278,592    49,307    229,285    465% 
Total operating expenses  $8,566,876   $8,133,114   $433,762    5% 

 

The increase in operating expenses was primarily attributed to increases in management compensation offset by a decrease in cost of revenue and professional fees.

 

 

 

 37 

 

 

Cost of revenue

 

   Six months ended         
   June 30,         
   2026   2025   Change   % 
Cost of inventory  $372,848   $821,234   $(448,386)   (55%)
Freight and shipping   8,090    6,059    2,031    34% 
Consulting and advisory-related party       4,000    (4,000)   (100%)
Royalty and sales commission-related party       56,290    (56,290)   (100%)
Rent expense   116,267    101,069    15,198    15% 
Total cost of revenue  $497,205   $988,652   $(491,447)   (50%)

 

During the six months ended June 30, 2026, the cost of revenue decreased over the six months ended June 30, 2025, primarily due to a decrease in cost of inventory.

 

Cost of inventory consists of product costs, direct labor, related supplies, and direct testing of our CitroTech product and the various components required for installation of CitroSafe™ systems. Cost of inventory decreased during the six months ended June 30, 2026, compared to the comparable 2025 period, primarily due to lower product sales volume.

 

Freight and shipping relate to costs for shipping products to customers.

 

Consulting and advisory services are to a related party company for services related to product installations.

 

We did not have royalty and sales commissions to a related party in the six months ended June 30, 2026. During the first quarter of 2025, we recognized $56,000 as an allocated portion of consulting and direct labor costs associated with our revenue as royalty and sales cost of revenue. In March 2025, we entered into a new contract under which the consulting and advisory royalty arrangement was terminated.

 

Rent expenses are warehouse and facility rent expenses. The increase in rent expense is primarily attributable to our relocation to a larger commercial facility for operations, warehousing, and customer-facing activities beginning in April 2025, along with the cancellation of a prior warehouse lease in May 2025.

 

Amortization and depreciation

 

Amortization and depreciation expenses are from the amortization of patents and technology and the depreciation of vehicle, and furniture and equipment.

 

General and administrative

 

General and administrative expenses are office, rent, travel, insurance, website, IT, public listing fees, and other office related expenses. For the six months ended June 30, 2026, we incurred increased expenditures on public listing fee, our website and IT development and travel as well as general office and insurance expenses from expansion of operations.

 

 

 

 

 38 

 

 

Advertising and marketing

 

The increase in advertising and marketing during the six months ended June 30, 2026, over the six months ended June 30, 2025, is primarily due to supporting revenue growth in addition to investor relations activities after being uplisted to the NYSE American. This includes rebranding efforts around the official company name change to CitroTech Inc. from General Enterprise Ventures Inc as well as the product labels moving from Mighty Fire Breaker to CitroTech and the conversion of relevant website and marketing materials. We attended and helped to fund events in the wildfire industry to expose leaders in the fire industry to the CitroTech product, which we believe will lead to sales in the future.

 

Professional fees

 

The professional fees during the six months ended June 30, 2026, primarily included stock-based compensation of $443,000 to advisors, and various professional fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2026. In addition, we had expenses related to the formation of the HexiTech Joint Venture between CitroTech and Hexion that were a one-time expense. The professional fees during the six months ended June 30, 2025, primarily included stock-based management compensation of $2.3 million, of which $2.1 million was to a related party consultant (TC Special Investments, LLC (“TCSI”)) and various professional fees for accounting and audit related to SEC filings, legal on patents and other consulting services in 2025.

 

TCSI’s consulting services to us include sales and business development, customer relationship management, strategy optimization, investor relations, underwriter interface, coordinating outside counsel and other business aspects at the request of the Board of Directors. In addition to TCSI, stock-based compensation was remitted to certain individuals with fire retardant and industry experience, who provided guidance and insight to our management and Board of Directors with respect to the fire retardant and fire inhibitor industry, business development connections, and oversight during the testing and recognition processes.

 

Payroll and management compensation

 

During the six months ended June 30, 2026, management compensation increased to $5.2 million from $3.0 million in the prior period. This increase was primarily attributable to the buildout of a full executive management team during 2025, including the appointment of a Chief Operating Officer, Chief Financial Officer, Chief Technology Officer, and General Counsel. Compensation during 2026, primarily included stock-based management compensation of $3.4 million, and payroll to management of $0.8 million and employees of approximately $1.1 million. The significant increase in stock-based compensation reflects the transition from a single-executive structure in the first quarter of 2025. Compensation during 2025, primarily included stock-based management compensation of $2.3 million and payroll to management of $0.5 million and employees of $0.2 million.

 

Research and development costs

 

We continue to invest heavily in the testing and certifications of CitroTech treated products as well as in advance of submitting formulas for approval to apply product onto federal lands. We expect to continue growing R&D spend over historical spend as we add additional product lines and invest in the future of the company. This includes funded research programs with Texas A&M on new products that were not underway in 2025.

 

Other Expenses

 

For the six months ended June 30, 2026 and 2025, the other expenses consisted of interest expense primarily related to convertible notes payable issued in 2025 of $973,000 and convertible notes payable issued in 2025 and 2024 of $1.2 million, respectively, change in fair value of derivative liability related to convertible notes payable issued in 2025 and 2024 of $0 and $3.8 million, respectively, financing expense of $0.4 million and $8.7 million, respectively, and loss on settlement of debt of $847,000 and $2.6 million, respectively. Settlement of debt in 2026 is the conversion of convertible notes issued in 2025. Settlement of debt in 2025 is conversion of convertible notes issued in 2024. Financing expense is from 4 million warrants granted to a financial advisor and 69,007 shares of Series C Convertible Preferred stock issued to BRH in 2025.

 

 

 

 39 

 

 

Net loss

 

The net loss for the six months ended June 30, 2026 was approximately $10.1 million, a decrease of approximately $12.7 million as compared to the six months ended June 30, 2025, primarily due to a significant reduction in other expenses, partially offset by lower revenue and higher operating expenses. 

 

Liquidity and Capital Resources

 

Sources of Liquidity

 

Since our inception, we have incurred significant operating losses and negative cash flows from our operations. Our net loss was $10.1 million and $22.8 million for the six months ended June 30, 2026 and 2025, respectively. During fiscal year 2025, we completed a debt offering in February and an equity offering in September and October which generated net proceeds of approximately $3.7 million and $8.1 million, respectively.

 

Working capital

 

   June 30,   December 31,     
   2026   2025   Change 
Current assets  $3,682,667   $7,415,426   $(3,732,759)
Current liabilities   420,088    2,169,626    (1,749,538)
Working capital  $3,262,579   $5,245,800   $(1,983,221)

 

As of June 30, 2026 and December 31, 2025, the current assets consisted of cash of $2.5 million and $6.3 million, respectively, inventory of $579,000 and $621,000, respectively, accounts receivable of $165,000 and $209,000, respectively, and prepaid expenses and other current assets of $419,000 and $317,000, respectively.

 

As of June 30, 2026 and December 31, 2025, the current liabilities consisted of accounts payable and accrued liabilities of $222,000 and $316,000, respectively, deferred revenue of $21,000 and $3,000, respectively, due to related parties of $5,000 and $168,000, respectively, convertible notes net of discount of $0 and $219,000, respectively, convertible note – related party of $0 and $1.3 million, respectively, current portion of financing loan of $15,000 and $30,000 respectively, and current portion of operating lease liability of $157,000 and $148,000, respectively.

 

The decrease in working capital in 2026 was primarily due to a decrease in cash of $3.7 million for operating activities, offset by a decrease in convertible debt due to conversions into common stock.

  

Cash Flows

 

For the six months ended June 30, 2026 and 2025

 

   Six months ended     
   June 30,     
   2026   2025   Change 
Cash used in operating activities  $(3,842,728)  $(1,925,535)  $1,917,193 
Cash provided by (used in) investing activities   1,773    (167,744)   169,517 
Cash provided by financing activities   91,666    3,645,234    (3,553,568)
Net Change in cash  $(3,749,289)  $1,551,955   $(5,301,244)

 

 

 

 40 

 

 

Operating Activities

 

We have not generated positive cash flows from operating activities.

 

For the six months ended June 30, 2026, net cash flows used in operating activities consisted of a net loss of $10.1 million, reduced by stock-based compensation of $4.2 million, non-cash lease expenses of $78,000, amortization and depreciation of $250,000, amortization of debt discount of $892,000, loss on settlement of debt of $847,000, loss on disposal of equipment of $32,000, and increased by bad debt recovery of $20,000, and net changes in operating assets and liabilities of $33,000.

 

For the six months ended June 30, 2025, net cash flows used in operating activities consisted of a net loss of $22.8 million, reduced by stock-based compensation of $13.3 million, non-cash lease expenses of $86,000, amortization and depreciation of $151,000, amortization of debt discount of $1.0 million, loss on settlement of debt of $2.6 million and changes in derivative liability of $3.8 million, and increased by net changes in operating assets and liabilities of $110,000.

 

Investing Activities

 

For the six months ended June 30, 2026 and 2025, the net cash flows provided by (used in) investing activities consisted of the purchase of equipment of $11,000 and $168,000 and sales of equipment of $12,500 and $0, respectively. 

 

Financing Activities

 

For the six months ended June 30, 2026, net cash provided by financing activities consisted of $96,000 capital contribution from a related party and proceeds from the exercise of warrants of $25,000, and repayment of a financing loan of $30,000.

 

For the six months ended June 30, 2025, net cash provided by financing activities consisted of $260,000 proceeds from the issuance of Series C Convertible Preferred Stock, $3.7 million from the issuance of convertible promissory notes and associated warrants, $59,000 deferred offering cost payment, and repayment of loans of $241,000.

 

Contractual Obligations

 

Financing loans

 

We had a financing loan for the purchase of a vehicle in September 2025. The loan repayment is $2,021 per month for 60 months, beginning October 2025, with an interest rate of 11.33%.

 

Lease Agreements

 

We have one lease classified as an operating lease for office and warehouse purposes. The following table outlines maturities of our lease liabilities as of June 30, 2026: 

 

Year ending December 31,    
2026 (remaining six months)  $98,654 
2027   203,228 
2028   211,357 
2029   219,812 
2030   55,486 
    788,537 
Less: Imputed interest   (94,886)
Operating lease liabilities  $693,651 

 

 

 

 41 

 

 

Liquidity

 

We have incurred losses since inception and incurred a net loss of $10.1 million during the six months ended June 30, 2026. However, in September 2025, we completed an equity offering which generated net proceeds of $5.4 million. Additionally, in October 2025, we completed an equity offering which generated net proceeds of $2.7 million.

 

Our existing cash resources, if necessary, could provide sufficient funds to carry out our planned operations through fiscal year 2026. To more rapidly grow our revenue and continue operations beyond such time frame, we will be required to raise additional funds by completing additional equity or debt offerings or increasing revenue. We may also raise capital through public or private offerings of equity or debt securities or by entering into a credit facility. There can be no assurance that we will be successful in acquiring additional funding, that our projections of its future working capital needs will prove accurate, or that any additional funding would be sufficient to continue operations in future years.

 

Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to us, but which will only be resolved when one or more future events occur or fail to occur. In consultation with its legal counsel as appropriate, our management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against us or unasserted claims that may result in such proceedings, we, in consultation with legal counsel, evaluate the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein. If the assessment of a contingency indicates it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in our financial statements. If the assessment indicates a potentially material loss contingency is not probable, but is reasonably possible, or is likely, but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.

 

Critical Accounting Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”), which require management to make estimates, judgments and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes.

 

For a discussion of our critical accounting estimates, refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026 (the “Annual Report”). There have been no material changes to our critical accounting estimates as described in that Annual Report.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information specified under this item.

 

 

 

 

 42 

 

 

Item 4. Controls and Procedures.

 

Management’s Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Disclosure controls and procedures are controls and other procedures designed to ensure that the information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Based on an evaluation under the supervision and with the participation of the Company’s management, the Company’s principal executive officer and principal financial officer have concluded that the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act were effective as of June 30, 2026 to provide reasonable assurance that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms and (ii) accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

  

Changes in Internal Controls over Financial Reporting

 

There has been no change in the Company’s internal control over financial reporting during the three months ended June 30, 2026 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. Management will continue to monitor and evaluate the effectiveness of our internal controls over financial reporting on an ongoing basis and is committed to taking further action and implementing additional improvements as necessary.

 

 

 

 

 

 

 43 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we may be involved in various claims and legal proceedings relating to claims arising out of our operations. We are not currently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business, financial condition, and results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

 

Item 1A. Risk Factors.

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Quarterly Report. However, as of the date of this Quarterly Report, there have been no material changes with respect to those risk factors previously disclosed in the “Risk Factors” section of the Annual Report. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the three months ended June 30, 2026, the Company issued 408,334 unregistered shares of Common Stock as follows:

 

  · 33,333 shares of Common Stock issued to consultants for services, valued at $282,997; and
  · 375,001 shares of Common Stock issued on conversion of 112,500 shares of Series C Convertible Preferred Stock

 

The offers and sales of the above securities were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act or Regulation D promulgated thereunder. The recipients of the above securities represented that they acquired the securities for investment only and not with a view to or for sale in connection with any distribution thereof.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not Applicable.

 

Item 5. Other Information.

 

(a) None.

 

(b) None.

 

(c) During the quarter ended June 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 44 

 

 

Item 6. Exhibits.

 

        Incorporated by Reference

 

Exhibit

Number

  Exhibit Description   Form   Exhibit   Filing Date/
Period End Date
3.1   Articles of Domestication/Articles of Incorporation   10-K   3.1   04/15/2024
3.2   Amendment to Articles of Incorporation   10-K   3.2   03/31/2025
3.3   Amendment to Articles of Incorporation   8-K   3.1   09/10/2025
3.4   Amended and Restated Bylaws   10-Q   3.4   11/12/2025
3.5   Second Amended and Restated Designations and Preferences of Series A Preferred Stock   10-K   3.4   03/31/2025
3.6   Amended and Restated Designations and Preferences of Series C Convertible Preferred Stock   10-K   3.5   03/31/2025
3.7   Articles of Amendment to the Articles of Incorporation   8-K   3.1   01/28/2026
3.8   Certificate of Name Change   8-K   3.2   01/28/2026
4.1   Warrant Agreement dated April 7, 2026, by and between the Company and BoltRock Holdings, LLC   S-1   4.11   04/09/2026
10.1   Transition Agreement, dated April 1, 2026, by and between CitroTech Inc. and Stephen Conboy   8-K   10.1   04/03/2026
10.2   Limited Liability Company Agreement of HexiTech LLC, dated April 17, 2026, by and between CitroTech Inc. and Hexion Inc.   8-K   10.1   04/21/2026
10.3   Intellectual Property License Agreement, dated April 17, 2026, by and among CitroTech Inc., Mighty Fire Breaker, LLC and HexiTech LLC   8-K   10.2   04/21/2026
10.4   Stock Exchange and Stockholders Agreement, dated May 28, 2026, by and between CitroTech Inc. and BoltRock Holdings, LLC   8-K   10.1   06/01/2026
10.5   Stock Exchange and Stockholders Agreement, dated May 28, 2026, by and between CitroTech Inc. and TC Special Investments LLC   8-K   10.2   06/01/2026
31.1*   Certification of Principal Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002            
31.2*   Certification of Principal Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002            
32.1**   Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002            
32.2**   Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002            
101.INS*   Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.            
101.SCH*   Inline XBRL Taxonomy Extension Schema Document            
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document            
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document            
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document            
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document            
104*   Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set.            

 

_________

* Filed herewith.

**Furnished herewith.

 

 

 

 45 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CitroTech Inc.  
       
Dated: August 10, 2026 By: /s/ Nanuk Warman  
    Nanuk Warman  
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 46